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Summary 
When testing a new biomaterial, the standard protocol before proceeding to clinical trials is to 
follow a battery of determined in vitro assays in order to select the most successful material to 
undergo in vivo experimentation. However, the lack of correlation between in vitro and in vivo 
experimentation is a critical and well-documented problematic to have in account when addressing 
the material compatibility on the biological context.  
In consequence, the search for new methodologies to approach the in vivo experimentation with 
more certainty is needed to avoid extra ethical and economic problems/costs when testing 
biomaterials, in specific for dental implantation purposes. 
One possibility could be the study of characterisation of the layer of proteins formed post-
implantation using mass spectrometry analysis (LC-MS/MS), as it comes as a possible and 
groundbreaking tool to assess and evaluate patterns of clusters of proteins related with 
biocompatibility problems, establishing a relationship with the future in vivo outcome. 
Subsequently, these clusters of proteins can be held responsible for macrophage activation and 
migration at the moment of implantation.  
Hence, the study of inflammatory markers expressed by each phenotype of macrophages when 
cultured onto biomaterials gains additional interest to establish an effective tool to approach the 
inflammatory response to a determined material. 
This thesis opens up the possibility of adopting these two methodologies as new potential tools to 
approach in vitro experimentation on the field of biomaterials for dental implantation purposes. 
Different biomaterials will be synthetized in a systematically way in order to obtain various 
biological responses. Physicochemical and biological (proteomic, in vitro and in vivo) 
characterisation will be done and results from different techniques correlated.  Results obtained 
on each group of biomaterials will be presented in each chapter of this document and will 
successfully establish some clear correlations between the in vitro (cell cultures and proteomics) 
and in vivo response, proving them feasible and conceivable to take up for a near future. 
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Resumen 
A la hora de probar un nuevo biomaterial, el protocolo estándar antes de proceder a los ensayos 
clínicos es seguir una batería de ensayos in vitro determinados con el fin de seleccionar el material 
más exitoso para someterse a la experimentación in vivo. Sin embargo, la falta de correlación entre 
la experimentación in vitro e in vivo es una problemática crítica y bien documentada que debe 
tenerse en cuenta al abordar la compatibilidad del material en el contexto biológico. 
En consecuencia, la búsqueda de nuevas metodologías para abordar la experimentación in vivo 
con más certeza es necesaria para evitar problemas y costes extra, tanto éticos y económicos, 
cuando se prueban biomateriales, en particular para fines de implantación dental. 
Una posibilidad podría ser el estudio de la caracterización de la capa de proteínas formada después 
de la implantación mediante análisis de espectrometría de masas (LC-MS / MS), ya que se presenta 
como una herramienta innovadora para evaluar patrones de grupos de proteínas relacionadas con 
problemas de biocompatibilidad, estableciendo una relación con el futuro resultado in vivo. 
Posteriormente, estos grupos de proteínas pueden ser responsables de la activación y migración 
de macrófagos en el momento de la implantación. 
Por lo tanto, el estudio de los marcadores inflamatorios expresados por cada fenotipo de 
macrófago cuando se cultivan en biomateriales gana un interés adicional para establecer una 
herramienta efectiva para abordar la respuesta inflamatoria a un material determinado. 
Esta tesis abre la posibilidad de adoptar estas dos metodologías como nuevas herramientas 
potenciales para abordar la experimentación in vitro en el campo de los biomateriales para fines 
de implantación dental. Se sintetizarán diferentes biomateriales de forma sistemática para obtener 
diversas respuestas biológicas. Se realizará una caracterización fisicoquímica y biológica 
(proteómica, in vitro e in vivo) y se correlacionarán los resultados de diferentes técnicas. Los 
resultados obtenidos en cada grupo de biomateriales se presentarán en cada capítulo de este 
documento y establecerán con éxito algunas correlaciones claras entre la respuesta in vitro 
(cultivos celulares y proteómica) y la respuesta in vivo, demostrando que estas correlaciones son 
factibles y concebibles para asumir en un futuro próximo. 
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Resúm 
A l´hora de provar un nou biomaterial, el protocol estàndard abans de procedir amb els assajos 
clínics, és seguir una bateria d’assajos in vitro determinats per tal de seleccionar el material més 
exitós per a sotmetre a l’experimentació in vivo. Però, la falta de correlació entre l’experimentació 
in vivo i in vivo  és una problemàtica crítica i bé documentada que ha de tenir-se en compte en 
abordar la compatibilitat del material en el context biològic. 
En conseqüència, la recerca de noves tecnologies per abordar amb més certesa l’experimentació 
in vivo és necessària per evitar problemes i costos extra, tant ètics com econòmics, quan es proven 
biomaterials, en particular per a fins d’implantació dental. 
Una possibilitat podria ser l’estudi de la caracterització de la capa de proteïnes formada després 
de la implantació mediant anàlisi d’espectrometria de masses (LC-MS / MS), ja que se presenta 
com una eina innovadora per avaluar patrons de grups de proteïnes relacionades amb problemes 
de biocompatibilitat, establint una relació amb el futur resultat in vivo. 
Per tant, l’estudi dels marcadors inflamatoris expressats per cada fenotip dels macròfags quan es 
cultiven en biomaterials guanya un interès addicional per establir una eina efectiva  per abordar la 
resposta inflamatòria a un material determinat. 
Aquesta tesi obri la possibilitat d’adoptar aquestes dues metodologies com noves eines potencials 
per abordar l’experimentació in vitro en el camp dels biomaterials per a fins d’implantació dental. 
Es sintetitzaran diferents biomaterials de forma sistemàtica per obtenir diverses respostes 
biològiques. Es realitzarà una caracterització fisicoquímica i biològica (proteòmica, in vitro i in vivo) 
i es correlacionaran els resultats de diferents tècniques. Els resultats obtinguts en cada grup de 
biomaterials es presentaran en cada capítol  d’aquest document i establiran amb èxit algunes 
correlacions clares entre la resposta in vitro (cultius cel·lulars i proteòmica) i la resposta in vivo, 
demostrant que aquestes correlacions són factibles i concebibles per assumir en un futur pròxim.  
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 Bone Tissue biology 
Bone tissue is a specialized and mineralized connective tissue with a hierarchical organization 
comprising several degrees of length scales that go from macro-component to nanostructured 
organized matrices [1] , arranged either in a compact pattern (cortical bone tissue) or in a 
trabecular pattern (spongy bone) .  
Constituted by both mineral and organic phases, the hybrid composition of this tissue confers to it 
unique properties. At the same time that displays mechanical resistance and consequent flexibility, 
this specialized tissue is characterised by its stiffness, and it is constituted by various distinct and 
specialized types of cells.  
These properties exert, as a whole set, structural, locomotive, protective and storage functions to 
the soft tissues of a living organism, representing the permanent framework of the human body 
[2]. The continuous dynamic of bone metabolism is a feature of this tissue, being in constant 
remodulation throughout an individual lifespan. 
For dental implantology purposes, the bone tissue, as expected, is the fundamental object of study 
to follow the biological events of bone regeneration in response the implantation of a foreign body 
onto a living organism. 
However, the process known as osteogenesis is not the only one that plays the definite sequence 
of events culminating in the complete regeneration of bone tissue post-implantation.  
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 Bone healing following implant placement 
The bone regenerative process is a complex system comprised of a series of events involving a 
great number of cells, signalling molecules and pathways, well-timed and defined on their role, 
leading to phenoms of inflammation, coagulation, bone induction and conduction, that interplay 
actions between them, optimizing the impaired tissue to complete restauration of it [3].  
These are activated in response to a severe tissue trauma or defect such as it is a bone defect 
derived from an implantation of a foreign body onto the organism [4].  The bleeding resulting of 
that trauma will give the “kick-start” to a cascade of events and processes that will initiate the 
healing process of the affected tissue. 
Depending on the type of trauma, the bone healing development encompasses three overlapping 
main stages that follow specific patterns, actively changing cell behaviour, subsequent to constant 
changes of expression of genes that lead the whole process (Figure 1). 
 
Figure 1. The three overlapping phases of bone healing: inflammatory phase, bone formation phase and bone 
remodelling phase. Image collected from [5]. 
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In the specific case of dental implantation procedures, soft and hard tissue healing following 
implant placement leads to marginal soft tissue attachment and osseointegration [6], establishing 
the initial linkage to this phases. The minimal adaptation of the soft tissue to the implant surface 
has the function of settling a physical seal between the bone-surrounded implant surface and the 
oral microenvironment [7]. 
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1.2.1. Early and acute inflammatory response  
When a trauma following implantation is produced leading to, a haematoma is produced in 
response to the disruption of the tissue. This structure is produced in result of peripheral, 
intramedullary and bone marrow cell migration to the impaired tissue [8]. 
This haematoma eventually coagulates all around the damaged site, assembling a structural 
template for a posterior intermediate cartilaginous callus formation. This coagulation mainly 
involves the conversion of fibrinogen to fibrin in the defect gap, and its necessary to unleash cell, 
factor and mediator migration, removal of debris, processes ultimately required to ulterior 
angiogenesis of the bone tissue [9].  
The activated platelets resulting from the trauma release growth factors such as platelet-derived 
growth factor (PDGF) and transforming growth factor β (TGF-β) into the microenvironment 
surrounding the affected site, thus triggering the influx of inflammatory cells. 
In parallel, during this phase, the secretion of pro-inflammatory cytokines such as TNF-α, IL1β, IL-
6, IL-11 and IL-18 is activated, a commitment between immune and coagulation systems, 
promoting macrophage, lymphocyte and polymorphonuclear leukocyte chemotaxis to the affected 
tissue [10]. The secretion of these cytokines, besides the recruitment of immune response cells, is 
regarded too as having a secondary role on the following osteogenesis, especially on MSCs [11]. 
The following steps involve fibroblast migration, collagen and growth factor production and release, 
steadily turning the haematoma into a soft callus, overlapping the inflammatory phase, and 
initiating the bone formation phase [12] (Figure 2).   
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Figure 2. Development of the inflammatory processes and cytokine liberation in response to a 
trauma/fracture. 
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1.2.2. Bone formation phase 
The combined release of these growth factors, namely bone morphogenetic proteins (BMPs) and 
the mentioned inflammatory mediators, will ultimately unleash the recruitment of MSCs to the 
fracture site, providing guidance to proliferative and differentiative processes, initiating the 
following bone formation phase [10] 
The newly-formed soft callus will set up the events leading to new bone tissue formation and will 
be driven mainly by fibroblasts. This phase, also known by proliferative phase, is characterized by 
the early angiogenesis of fibrous tissue between the fragmented bone ends, in a stable and fixed 
position of them.  
In this phase, the soft callus is progressively converted to hard callus, also known as woven bone. 
The differentiation of osteoblasts and chondrocytes , consequent mineralization and bone matrix 
production, progressing to the fracture line, will allow formation of  the new trabeculae 
surrounding the fractured area, in a thicker density than the previous impaired bone [13]. In this 
phase is observable a predominance of angiogenic factors and metalloproteinases, such as VEGF 
and angiopoietins 1 and 2, and a high expression of type I collagen, that will endow this new formed 
bone of the vascularization needed to the final bone remodelling phase. 
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1.2.3. Bone remodelling phase 
Bone remodelling is part of the dynamic mechanism required for the maintenance of the bone 
structural architecture in response to mechanical needs of the organism, but also is part of a whole 
system that acts promptly in the repair of the impaired tissue following injury.  
This process relies mainly on two types of cells of the bone tissue: the osteoblasts, that display 
osteogenic functions; and the osteoclasts, large and multinucleated cells responsible for bone 
matrix degradation.   
The balance between the activities of these two types of cells define a good bone health and 
maintenance [14].   
The impairment of this balance can have critical consequences on an individual’s bone tissue health, 
being the osteoporosis one of the most widely known pathologies caused by this imbalance, due 
to excessive bone resorption by osteoclasts [15,16]. 
The callus is a physiological reaction to inter-fragmentary movement, requiring the presence of 
adequate blood flow and healthy cell viability [17]. In that sense, bone remodelling is part of the 
dynamic mechanism required for the maintenance of the bone structural architecture in response 
to mechanical needs of the organism, but also is part of a whole system that acts promptly in the 
repair of the impaired tissue following implantation. 
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Figure 3. Development and evolution of the latter phases of bone healing – Bone formation and remodelling. 
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 Bone healing post implantation 
The necessity for the human being to live a longer and healthier life has exerted the lookout for 
materials with the capability of restoring lost or damaged body parts. In consequence, in the last 
years, the field of dental implantology research and industry has arised as one of the most 
technologically advanced when concerning biomedical purposes.  
Tooth loss, or edentulism, is an event that might happen as a final consequence for the existence 
of disease or trauma [18,19]. In response to that problematic, dental implants are envisioned in 
order to replace the natural root of the missing tooth and posterior installation of a dental 
prothesis, and can even be traced back to the early civilizations, where the missing teeth were 
replaced by shells, bones and gold [20]. Due to the amount of time in history dental implants had 
been used, multiple factors have been recognized as fundamental to obtain a successful 
osseointegration outcome, such as implant design (including surface design), biomechanical 
factors, the host health and respective bone quality, and the type of biomaterial employed [21]. 
As defined by Williams DF [22], “ A biomaterial is a substance that has been engineered to take a 
form which, alone or as part of a complex system, is used to direct by control of interactions with 
components of living systems, the course of any therapeutic or diagnostic procedure, in human or 
veterinary medicine” , with the goal of restoring or enhance impaired tissues following trauma or 
disease. 
In effect, the development of materials for biomedical purposes, in this case for dental 
implantation, has changed its focus on the last 30 years from being a simple replacement 
biologically inert device, to be supplemented with biologically active materials [20,23]. 
Among the biomaterials used, it is accountable a large selection of metals, polymers, carbons, and 
combinations of them to be employed for a dental implant development [21,24,25]. 
In that sense, Titanium (Ti) and its alloys have become the reference metal to use for dental 
application and biomedical purposes, as it boosts great osseointegrative properties. Its corrosive 
resistance to bodily fluids and its osteoconductive potential for cell proliferation and 
differentiation makes Ti an excellent substrate for tissue growth [26]. Although is bioinert, Ti 
surfaces can be modified in order to enhance cell activation and following tissue regeneration. 
These surface modifications can include mechanical and chemical treatments that directly affect 
 32 
 
biocompatibility and include surface texture (roughness), ion binding sites, and even 
hydrophobicity alterations [27].  
Moreover, many distinct types of coatings have been tested to provide the implant surface with 
antibacterial properties to enhance for example cell anchorage, growth and colonization all around 
the device surface with bactericidal compounds as gentamicin, tetracyclin and octenidin [28–30]. 
Other strategies include coating the implant surface with growth factors such as TGF-β and BMP, 
described as enhancers of bone healing, and allow their controlled dissemination on the 
surrounding tissue [31–34]. 
They act by degrading compounds gradually onto the microenvironment around the implant 
providing a doped environment capable of exerting some influence on the surrounding cells and 
biological tissues in contact with it.  
In this aspect, achieving an optimal and correct bone healing after a dental implantation procedure 
in the lesser time possible is the prime objective when developing biomaterials for bone 
implantation [25]. So, it is of major importance understanding phenoms such as osteoinduction 
and osteoconduction, that lead to a complete osseointegration of a material on the living organism 
microenvironment, with a successful stability and longevity [35]. 
In that sense, the third generation of biomaterials, specifically for dental application, represent a 
hallmark on the development of biocompatible materials. This generation combines the bioactive 
and the resorbable characteristics of the second-generation in a synergistic formulation, allowing 
organism self-healing, post-implantation [36].  
This group of materials seek the modulation of the cell behaviour to generate the best possible 
outcome of it on a living organism microenvironment, even at a molecular level, both relying on 
the controlled liberation of compounds, genes and growth factors capable of improving the 
osteogenesis process and even physico-chemical surface modifications [37,38].  
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 Osseointegration 
The extent of the integration of the biomaterial in a living organism setting is dependent on several 
factors, many of which involved onto the microenvironment formed shortly after the moment of 
implantation.  
Activation of coagulation cascades, antibody production, platelet activation, adhesion and 
aggregation are all part of the major characteristics involved on the generic host response to 
biomaterial implantation onto the organism setting.  
These characteristics can be led by the first layer of proteins adsorbed onto the material surface, 
considered major key players on the activation of all of these processes. It is generally believed 
that the composition, conformation and type of these proteins interplay a key role on the following 
host processes in response to the contact with the foreign body [39,40]. 
These will deposit onto its surface by competitive displacement, called “Vroman effect”, initiating 
the whole process of regeneration [41]. This “Vroman effect” describes the competitive nature of 
proteins adsorbed onto a determined surface depending on the molecular weight of the protein 
[42]. These proteins, at the moment of implantation, are mostly derived by blood plasma, one of 
the first fluids in contact with the implant surface [43].  
These will unleash events like initial cell adhesion and consequent intrinsic cell processes, like 
cellular proliferation and differentiation [44]. 
The type, conformation and quantity of these proteins is dependent not only on the organism in 
which the material is implanted, but also of the characteristics of the material, regarding physico 
and chemical properties such as hydrophilic potential, surface chemistry, and micro- and/or nano-
roughness, as mentioned. 
The adsorption post-implantation of blood proteins will immediately cause the formation of a 
blood clot, composed mainly by growth factors and cytokines that will evoke cell migration to the 
implanted site [45].  
This migration occur due to the interaction of cell adhesion receptors with the adsorbed proteins, 
being the first step on the activation of the mentioned immune response processes [46]. In specific, 
proteins adsorbed on the surface of biomaterials (such as fibrinogen, fibronectin, vitronectin, 
complement component C3b, among others) are crucial for the implant recognition and initiation 
of a foreign body reaction to an implant surface [45].  
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Firstly, the non-specific protein adsorption onto the implant, together with the immune and 
inflammatory response, will occur in order to protect the organism from the foreign body, in a 
determined magnitude [47,48].  
The immune response process shares some traits and interactions with the bone formation 
processes (e.g. osteogenesis), by consequence forming the field of osteoimmunology [49]. In fact, 
bone cells are described to have a role on the maintenance, homeostasis and mobilization of the 
HSCs (Hematopoietic Stem Cells), being considered part of the immune processes system by some 
authors [50]. Such implant-adhered proteins are then recognized by macrophage integrins, like 
macrophage-1 antigen (CD11b/CD18) and arginine-glycine-aspartic (RGD sequence) acid-binding 
integrins avb3, avb5, and a5b1 [51]. In fact, it is described that when the coating containing the 
RGD peptide is applied to a titanium surface significantly enhance bone formation and osteoblastic 
activity [52,53], and at the same time is capable of modulating the immune response by 
macrophages [48]  
Shortly, the following “sub-processes” intervein in one way or the other on the bone tissue healing 
process development, which are coordinated on great part by specific proteins or protein clusters. 
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Figure 4. Processes involved on bone tissue regeneration and interaction between them. 
 
1.4.1. Immune response 
This phase is mainly driven by complement proteins that unleash mechanisms of innate and 
acquired immunity. The complement cluster is comprised by a series of proteins synthesised on 
the liver and on cell surfaces in an inactive form, also called zymogens [54]. It follows a coordinated 
sequence of events and interactions between these with the final goal of recognizing and 
opsonizing the pathogen, leading to its lysis, triggering the inflammatory response. Depending on 
the type and quantity of the proteins involved, as well as the type of pathogen surface recognition, 
the complement system can act by distinct pathways resulting in the generation of C3 convertases, 
the core and common component of all the complement pathway systems [55]. Each pathway acts 
dependent on the recognition of the distinct signalling molecules. 
The classical pathway is usually initiated from the interaction of C1q with pentraxins, such as C-
reactive protein, or antigen/antibody binding with IgG or IgM, leading to C1r activation and C2s 
cleavage. Following these events, serine proteases are activated, leading to the cleavage of C4 and 
C2, ultimately originating the C3 convertase C4b2a, which breaks C3 into C3a and C3b [56]. C3a is 
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described to have the function of recruitment of inflammatory cells to the site, while C3b interacts 
with C5, assembling with C6, C7, C8 and C9 the Membrane attack complex (MAC), a structure that 
forms transmembrane channels disrupts onto the pathogen membrane, facilitating its lysis [57]. 
This pathway is the most commonly activated in response to the recognition of immune complexes. 
The alternative pathway is mostly driven by the low continuous formation of a soluble C3 
convertase, which results in the formation of a conformationally distinct C3, named C3 (H2O), 
capable of binding factor B. Following this binding, the change of conformation factor B allows its 
cleavage by the serum protease factor D, resulting in the generation of Ba and Bb. This Bb fragment 
is in its turn, capable of cleaving C3 molecules, forming C3b, generating more C3 convertases [58]. 
This pathway is the most commonly activated in response to the recognition to pathogen surfaces. 
Finally, the lectin pathway relies mostly by the binding of mannose-binding lectins (MASPs) and 
ficolins to the C4 and later to C2, having later a similar pathway to the classical complement 
pathway, except on their initial activation [59]. This pathway is mostly common from the 
recognition of e.g. microbial carbohydrates. 
 
 
Figure 5. Pathways of complement activation. Image inspired by [54] 
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1.4.2. Osteogenesis 
 On this process intervene a great amount of proteins that will have a role on the osteoblastic cell 
response and consequent differentiation, topping the bone formation process in the literal sense 
of the event.  
In response to chemical signalling and physical stress, specific signalling pathways are activated, 
such as the mitogen-activated kinase pathway (MAPK) that will allow the linkage between 
mechanical interactions with the ECM and activation of Runx2. This central control gene is 
considered to be defining of the osteoblast phenotype [60]. The induction of a determined 
osteoblastic phenotype requires interactions between osteoblastic precursors and the non-
collagenous extracellular matrix secreted by this kind of cells [61]. This ECM of osteoblasts is 
comprised by collagenous and non-collagenous proteins, bone morphogenic proteins (BMPs) and 
growth factors that, depending on their expression profile, and controlled release will establish the 
rate of osteoblastic differentiation and consequent bone formation. Proteins like collagen I, BMP-
2, BMP-7, and matrix metalloproteases (MMPs) are described to be key players on the 
development of this process [60,62].  
  
 
1.4.3. Coagulation 
 
In short, the main purpose of the coagulatory processes is to form a fibrin mesh made from a great 
amount of platelets, leading ultimately to the formation of a haemostatic plug, preventing the 
continued bleeding [63,64]. 
This complex process was initially thought to start by the exposure of the damaged/impaired tissue 
to a group of proteins known as Tissue Factors (TF). 
It can be activated by mainly two pathways: an intrinsic and extrinsic pathway. The extrinsic 
pathway generally occurs in response to a trauma, where TF is produced during a trauma, and it 
works by activating factor VII (FVII) into FVIIa, leading to the production of extrinsic tenase 
complexes (TF-FVIIa) [63] . The TF can be produced by macrophages, endothelial cells, monocytes, 
among others following damage or impairment of the tissue, or in response to inflammatory 
stimuli as TNF-α and IL1α release [65,66]. 
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The intrinsic pathway usually is activated by mixed surface contacts of proteins such as 
prekallikrein, kininogen and Factor XII (FXII), forming a sequential cascade of complexes zymogen-
enzyme, on some steps depending on Ca2+ ion participation. This ultimately leads to the conversion 
of prothrombin to thrombin, the end product of the whole cascade, responsible for the catalysis 
of fibrinogen onto fibrin. On this step of bone healing, multiple growth factors of platelets are 
involved, such as TGF-β and IGF-1 [67]. 
 
 
 
1.4.4. Fibrinolysis  
Intrinsically involved with the coagulation system, the fibrinolytic system is complex and a key part 
of the haemostasis processes, as it degrades the fibrin, product of the coagulation process and the 
substrate for the development of this process [68].  Two main events take place during the 
development and occurrence of this stage: the generation of plasmin, enzyme with blood plasma 
proteolytic activity; and subsequent degradation of fibrin by this enzyme [69]. Plasmin is generated 
from the zymogen plasminogen on the cell or fibrin clot surface and it is controlled by plasminogen 
activators, namely the tissue plasminogen activator (tPA) and the the urokinase plasminogen 
activator (uPA) and regulated by a series of other mechanisms and inhibitors.  
Among these, the tissue plasminogen activator (tPA) is the most widely known and studied and it 
is regarded as being one main thrombolytic agent for acute isquemic stroke [70]. Its assembly on 
the fibrin surface, dependent of the lysine-binding sites, enables the formation of a complex tPA-
plasminogen, in which the plasminogen is cleaved, generating plasmin. In parallel, the urokinase 
plasminogen activator is also described to cleave plasminogen, although with less affinity [68]. The 
consequent generation of fibrin by the plasmin is thus giving place to fibrin degradation products, 
which are described to have both immunomodulatory [71] and thromboregulatory effects [72]. 
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 Current approaches on the development of biomaterials 
To this day, the present approach on biological biomaterial evaluation is banked almost entirely on 
the cell reaction to the exposure to a determined biomaterial with determined and protocolled in 
vitro assays, part of a filtering process that enables the material pre-selection for in vivo evaluation 
of materials and posterior clinical trial.  
The exposure of the cell to the material can occur by direct or indirect contact, and the parameters 
evaluated contemplate not only the material cytotoxicity, but also if the proliferation and 
differentiation potential are affected positively or negatively by that exposure [73]. Moreover, 
these in vitro studies tend to focus on the bone tissue-forming potential of the material, mainly 
working with cell lines correlated with osteogenesis [74,75]. This represents a costly limitation to 
the studies, as they don’t contemplate nor simulate completely what happens in an in vivo context.  
This fact is well documented in Hulsart et al. [76], that presents the lack of correlative data between 
in vivo and in vitro evaluations of materials, presenting exceptionally low percentages of 
correlation. This lack of correlation is, of course, due to the no-contemplation of other processes 
associated with the whole regenerative process of bone, such as immune response to foreign body 
and coagulation cascades that affect equally the final outcome of the bone healing post-
implantation.  
This leads ultimately to costly and time-consuming consequences at the hour of evaluate whether 
if the material will osseointegrate perfectly onto the biological context.  
Hence, and in consequence, the bone material development paradigm is shifting towards the field 
of osteoimmunology, envisaging the immune system process and its interactions with the other 
biological processes, in an effort to enhance and strengthen the possibilities of a successful 
outcome of a biomaterial. In fact, a recent review on dental and orthopaedic addresses this 
problematic, finding that almost 90% of research in this area exclusively focus on the in vitro 
behaviour of osteoblasts on surfaces, with the remaining 10% contemplating the immune cell 
demeanour (macrophages, monocytes, leukocytes and multinucleated giant cells) [77]. 
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By this reason, the current standard assays only using one cell line (osteoblasts), that do not 
contemplate the inflammatory processes are too limited to assess the biomaterial behaviour in 
vivo, and by that fact, can lead to serious complications when testing them in the biological context. 
Thus, this fact arises the need to work with alternative cellular lines, like macrophages or 
monocytes, to appraise the potential inflammatory response to a biomaterial. 
 
 Macrophage polarization – critical role on osseointegration 
The homeostasis of the immune cell state is critical for the tissue development, regeneration and 
repair [78]. As mentioned, the implant subsequent development of the microenvironment cues 
will be dependant on the biomaterial implanted, and on of the organism “foreign body reaction” 
(FBR) to the biomaterial. This FBR results in the formation of a granuloma fibrous tissue, which in 
turn can follow two paths: the desired wound/damaged site healing or the undesired fibrous tissue 
formation.  
In that sense, macrophages are major key players on these processes, differentiating from 
monocytes and mediating the inflammatory events that lead wound healing processes post-
implantation [79,80]. 
Being the most plastic cells of the hematopoietic system, macrophages are scattered through all 
human body tissues with variate roles, namely of tissue repairing and immunity purposes. They get 
activated in response to the microenvironmental cues provoked by the released cytokines.  
Following their activation, macrophages are both responsible for the recruitment of other immune 
cells to the impaired tissue by secreting a wide array of inflammatory mediators and natural 
pathogen removal by phagocytosis [81].  
Early studies in the 80`s, suggested a role of macrophages in the bone regenerative processes as 
their presence was always found near the bone surface and  adjacent to mature osteoblasts [82,83]. 
This fact opened the hypothesis of the possible and active role of macrophages on the bone 
formation development and biology. 
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The bone renewal and regenerative processes in response to an injury require the eviction of 
dead/damaged/old cells belonging to the impaired tissue [84]. Throughout this process, and 
naturally, macrophages will intervene and initiate the mentioned inflammatory processes. 
Although their role on these processes are widely known and studied, evidences regarding the role 
of these cells and their interaction with osteoblasts are still unknown.  
Specifically, resident (osteal) macrophages are described to have a central role on bone 
metabolism. Bone tissue enclose a determined population of this type of cells and they are thought 
to provide pro-anabolic support for osteoblasts, the prime bone tissue formation cells [83]. 
Moreover, in vitro studies strongly suggest an critical role of these cells on the sketetal health [85]. 
Raggatt et al. have proven that the depletion of these macrophages on the post-inflammatory 
anabolic phase of the bone tissue repair leads to inhibition of the callus, consequent endochondral 
tissue formation and less bone deposition. In parallel, the same study shows that the injection of 
pro-macrophage stimulation factor-1 a few days after fracture enhances the formation of soft 
callus [86]. In another study, it has been shown that the marrow containing macrophages from 
juvenile mice (4-weeks old), when transplanted onto middle-aged mice, facilitates bone healing 
and enhances callus formation [87].  
Hence, in the biomaterial implantation context, the adherent macrophages to the biomaterial 
become activated not only to attempt to phagocytose the material [45], but also to unleash the 
bone regenerative processes associated with osteoblasts. 
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1.6.1. Macrophage functional states and immune responses  
Depending on their functional states, macrophages can display two main ways of activation leading 
to two distinct phenotypes. 
These macrophage activation phenotypes are identifiable nowadays by reference markers, both 
membrane proteins and distinct cytokine expression profiles [88]. 
The classically activated macrophages, also known as M1 subtype, due to the dependence of Th1 
lymphocytes, secrete pro-inflammatory cytokines like TNF-α, IL1-β, IL-6, IL-8, in response to TLR 
and CLR activation by invading organisms/foreign bodies. They typically express chemokines CXCR3 
and CCR5 which promote the recruitment of leukocytes involved in tissue repair and remodelling 
[89,90]. 
The alternatively activated phenotype, also known as M2, is dependent of the Th2-type 
lymphocytes, and they possess the ability to suppress inflammation processes [91]. M2 cells can 
clear apoptotic cells and promote wound healing, besides promoting angiogenesis. M2 express 
different cytokines than M1, having a pattern of cytokine production of typically IL-10high and IL-
12low [92,93]. They preferentially occur in diseased tissues where they can induce the proliferation 
of endothelial cells [94]. This phenotype, which displays high phenotypic heterogeneity, has at least 
three main subdivisions: M2a, M2b and M2c, each one capable of being activated by a different 
set of immune complexes [95], with distinct specific functions of immunoregulation, tissue 
remodelling and angiogenesis [96]. However, the differences between these sub phenotypes is not 
well clear, and the diversity of results makes it difficult to reach a consensus  regarding this entity 
[95,97,98]. 
In the broad sense, the M1 phenotype shift naturally towards the M2 phenotype during the tissue 
remodelling process [99]. , M1 macrophages are predominantly found at early timepoints (1-5 days) 
after implantation, while M2, apart from having an initial presence, are mostly common at latter 
stages of the bone healing processes [100,101]. Pointedly, the early phase of the tissue repair post-
implantation is dominated by the presence of the inflammatory M1 phenotype. A progressive 
switch to M2 anti-inflammatory shift with a consequent osteogenic cytokine release then occurs, 
promoting the initiation of the bone formation and bone remodelling phases.  (Figure 6) 
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Figure 6. Normal macrophage phenotype changes during the formation of new bone. Based on [102]. 
 
The continued prevalence and unbalance of the M1 phenotype during the inflammatory stage can 
lead to fibrosis and consequent rejection of the implant, as macrophages are highly regarded as 
regulators of the fibrotic healing development of the wound [103] (Figure 7) 
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Figure 7. Macrophage phenotype change during the formation of fibrous capsule. Based on [102] 
This can lead to immediate implantation-related pathologies such as chronic inflammation, acute 
and chronic pain, ultimately leading to implant rejection. 
 
1.6.2.  Macrophages and osteogenesis 
Regarding bone healing processes, there is still a great way to go in order to establish the precise 
role of each phenotype on the development and renewal of the bone tissue. Schlundt et al. [104] 
have proven the influence and prevalence of each phenotype of macrophages on the evolution of 
a bone fracture. The predominance of M2 phenotype macrophages onto the fracture surroundings 
from 3 to 7 days post-trauma has led the authors to investigate the possible role of this phenotype 
as a therapeutic target for bone, as the induction of this phenotype through IL-4 and IL-13 has 
shown increased bone tissue angiogenesis by stimulating the osteogenic differentiation of MSCs 
[105]. 
Moreover, it has been shown that the depletion of this cells onto mice decreases the quantity of 
mineralized tissue, in particular during the stage of the endochondral ossification, when compared 
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to wild-type mice, reducing the healing time, which supposes a significant role for macrophages at 
the time in which these processes occur [106]. 
Some other studies refer that the prolonged predominance of M1 phenotype cells post-trauma 
impairs the recovery time and successfulness [107,108].  
Taking this into account, to control the M1/M2 ratio following implantation of biomaterials might 
be an essential and relevant aspect not only to determine whether if the procedure is successful 
regarding immune responses, but also in regard to define their contribution to bone homeostasis 
[109,110].  
 
1.6.3.  Protein deposition and macrophage modulation 
The protein deposition phenomenon will be the defining of this ratio, as it will unleash the 
mechanisms of activation of macrophages to the implanted site, and, depending on the type, 
amount and conformation of them, will promote phenotypical changes onto one or other 
phenotype, as time progresses (Figure 8). 
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Figure 8. Evolution of protein deposition and macrophage phenotype modulation onto an implant surface. 
 
The complexity of the bone healing in this context can depend on the gene expression profiles 
belonging to each phenotype and consequent interactions involved on these processes.  
Some studies are starting to be made on this topic, in an attempt to modulate the immune 
response controlling the macrophage polarization as a strategy to improve the tissue repair 
outcomes in response to biomaterials.  
Li et al. [111] evaluated changes on macrophage phenotype when  cells were cultured onto 
titanium discs supplemented with different magnesium concentration, through the membrane 
markers for each phenotype (CCR7 for M1 and CD206 for M2). They have found out that 
magnesium induced the phenotypical change into M2. Plus, the cells were capable of liberating 
anti-inflammatory cytokines IL4 and IL10 and had upregulated expression profiles of BMP-2 and 
VEGF, confirming the anti-inflammatory and wound healing potential of the tested materials. In 
another study, Fernandes et al. [112] have tested the effects of surface properties of bone implants 
 47 
 
coated with hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP) on macrophage cultures, 
finding out that the coatings induced increased secretion of pro- and anti-inflammatory cytokines 
on these coatings when compared to control Ti. Moreover, HA was observed to induce earlier 
phenotypic shifts to M1 rather than the β-TCP.  
 
 
1.6.4.  Complement proteins and macrophage polarization 
As described above, the activation of the complement system starts with a protein recognition step, 
mainly involving C1q, mannan binding lectin (MBL), and ficolins, known as innate pattern 
recognition receptors (PRRs), capable of recognizing the pathogen, initiating the pathway leading 
to its lysis.  
In the dental implantology context, the deposition of these signaling proteins following the 
procedure and consequent contact with blood, are dependent on the amount, type and 
conformation onto the implant surface and may signal whether if a material can be more “harmful” 
to the organism and activate the implant cascades in a specific magnitude. This magnitude can 
ultimately lead to the predominant activation of each one of the phenotypes. Therefore, the 
cellular response might be dependable on the type of proteins adsorbed to a material surface. 
Dependent on the recognition protein that become attached to a biomaterial, the complement 
pathway is triggered as described above, having as a final product the release of C3a and C3b by 
C3 convertases. 
Major players on the complement-derived response, macrophages express various complement 
receptors as CR1 (CD35), CR3 (CD11b/CD18), CR4 (CD11c/CD18), besides binding complement 
opsonins C1q, C3b and C5b, which can be adsorbed onto surfaces or cell membranes [113] (Figure 
9). In this regard, it has been shown and proven that C1q binds to macrophages directly modulating 
the cell response [114]. 
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The complement components C3, C5 and the C5b-9 are described as capable of modulating the 
macrophage functional M1 phenotype, by the binding of C3a and C5a anaphylatoxins, resultant of 
C3 and C5 convertases, to undifferentiated macrophages. At the same time, the opsonization of 
the implant surface by C1q and C3b shift the cytokine production towards the differentiation onto 
an M2 phenotype [115]. On the specific case of C1q, this shift is said to occur towards apoptotic 
cells and during clearance of modified lipoproteins in atherosclerosis, as a measure to prevent 
autoimmunity and preserve tissue homeostasis [114,116,117]. Moreover, it weakens TLR signaling 
suggesting reverse inflammatory polarization, in which MBL are still described to be involved due 
to their similarity [118]. However, there is still a long way to go to unravel the specific role of these 
proteins on the macrophage activation context. 
It remains to be seen the specific influence of these family of proteins on the biocompatibility 
outcome of a material. 
Hence, the strict relationship between complement adsorption on material surfaces and 
consequent immune response mechanisms associated with predominance of a certain type of 
macrophage phenotype is interesting to take up as a possible and approachable subject concerning 
biocompatible material evaluation. It might be interesting to predict in vivo outcomes adopting the 
study of the protein content adsorbed onto a biomaterial, relating it with cellular responses. 
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Figure 9. The interaction of macrophages with complement. Image based on [114]. 
In that sense, liquid-chromatography mass-spectrometry (LC-MS/MS) comes as a promising 
method to undertake this characterisation, due to its sensitivity, processing ability and high-
throughput analysis capability [119,120]. 
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2. Objectives 
In order to evaluate the outcome of biomaterials for clinical applications, such as for dental 
implementation, the in vivo testing is still a demanded step for the following up clinical trial testing. 
As of this day, there is no effective approach to evaluate a biomaterial, independent of systemic 
immune-suppressors or inhibitors, that can guarantee the implant outcome success. Assessing, 
characterizing and understanding the sequence of events taking place after implantation is decisive 
to develop materials capable of modulating the immune response by one side, and the 
osteoinductive and osteoconductive potential of the material by other.  One of the solutions could 
be by characterizing the layer of proteins adsorbed onto the surface of the implanted material, 
relating it with the predominance of a determined macrophage phenotype presence on it. 
In this context, the objective of this thesis is mainly focused on the discussion and development of 
a new possible methodology to assess in vitro experimentation for dental implantation purposes, 
regarding both the characterisation of the adsorbed layer of proteins formed post-implantation 
using liquid chromatography–mass spectrometry (LC-MS/MS) and the assessment of macrophage 
phenotype when in contact with a biomaterial.  The correlation between these and the in vivo 
outcome are assessed. 
 
Pointedly, this research work is centred on the assessment of the following questions: 
1) Is there a relationship between adsorbed proteins and biological response?  
2) Which proteins are associated with biocompatibility problems?  
3) Can the macrophage polarization be correlated with these protein adsorption patterns 
and possible emergence of biocompatibility problems?  
4) Can it be possible to predict the in vivo response with the study of macrophage 
polarization?  
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2. Objetivos 
Con el objetivo de evaluar el resultado de los biomateriales para aplicaciones clínicas, como la 
implementación dental, la experimentación in vivo sigue siendo un paso necesario para proceder 
a las siguientes pruebas de ensayos clínicos. 
Hoy en día, no existe un enfoque efectivo para evaluar un biomaterial, independientemente del 
uso de supresores inmunes o inhibidores sistémicos en contexto biológico, que pueda garantizar 
el éxito de una implantación.  
Evaluar, caracterizar y comprender la secuencia de eventos que tiene lugar después de la 
implantación es decisivo para desarrollar materiales capaces de modular, por un lado, su respuesta 
inmune y, por otro, maximizar su potencial osteoinductivo y osteoconductivo. Una de las 
soluciones podría ser caracterizar la capa de proteínas adsorbidas en la superficie del material 
implantado, relacionándolo con la mayor presencia de un determinado fenotipo de macrófago en 
él. 
En este contexto, el objetivo de esta tesis se centra principalmente en la discusión y desarrollo de 
una nueva metodología para evaluar la experimentación in vitro para la implantación dental, tanto 
en la caracterización de la capa de proteínas adsorbida después de la implantación mediante 
espectrometría de masas (LC-MS / MS) y la evaluación del fenotipo de macrófagos en contacto con 
un determinado biomaterial. La correlación entre estos y el resultado in vivo serán evaluadas. 
Concretamente, este trabajo de investigación se centra en la evaluación de las siguientes preguntas: 
1) ¿Existe una relación entre las proteínas adsorbidas y la respuesta biológica? 
2) ¿Qué proteínas están asociadas con problemas de biocompatibilidad? 
3) ¿Puede la polarización de los macrófagos correlacionarse con estos patrones de adsorción de 
proteínas y la posible aparición de problemas de biocompatibilidad? 
4) ¿Se puede predecir la respuesta in vivo con el estudio de la polarización de los macrófagos? 
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3. Experimental Design 
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ABSTRACT  
The success of a dental implant depends on its osseointegration, an important feature of the 
implant biocompatibility. In this study, two distinct sol-gel hybrid coating formulations (50% 
methyltrimethoxysilane: 50% 3-glycidoxypropyl-trimethoxysilane (50M50G) and 70% 
methyltrimethoxysilane with 30 % tetraethyl orthosilicate (70M30T)) were applied onto titanium 
implants. To evaluate their osseointegration, in vitro and in vivo assays were performed. Cell 
proliferation and differentiation in vitro did not show any differences between the 
coatings. However, four and eight weeks after in vivo implantation, the fibrous capsule area 
surrounding 50M50G-implant was 10 and 4 times, respectively, bigger than the area of connective 
tissue surrounding the 70M30T treated implant. Thus, the in vitro results gave no prediction or 
explanation for the 50M50G-implant failure in vivo. We hypothesized that the first protein layer 
adhered to the surface may have direct implication in implant osseointegration, and perhaps 
correlate with the in vivo outcome. Human serum was used for adsorption analysis on the 
biomaterials, the first layer of serum proteins adhered to the implant surface was analysed by 
proteomic analysis, using mass spectrometry (LC/MS/MS). From the 171 proteins identified; 30 
proteins were significantly enriched on the 50M50G implant surface. This group comprised 
numerous proteins of the immune complement system, including several subcomponents of the 
C1 complement, complement factor H, C4b-binding protein alpha chain, complement C5 and C-
reactive protein.  This result suggests that these proteins enriched in 50M50G surface might trigger 
the cascade leading to the formation of the fibrous capsule observed. The implications of these 
results could open up future possibilities to predict the biocompatibility problems in vivo. 
 
Keywords: sol-gel coatings, immune system, C-reactive protein, fibrous capsule, proteomics, 
osseoimmunology 
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a. INTRODUCTION 
In the design of implantable devices, the foreign body reaction, stress shielding, biocompatibility 
and (recently introduced) bioactivity and osteoinduction are the required features of the selected 
biomaterials and surface treatments [1]. 
Titanium (Ti) and its alloys are commonly used in dental implants with very good results due to 
their biocompatibility and biochemical properties. However, an increasing number of new 
biomaterials are being developed and applied to Ti surfaces as coatings [2,3]  to improve their 
existing properties or add new useful features (e.g., osteoinduction). 
New approaches must be assessed using reliable and comparable methods (in vitro and in vivo 
testing) to be rapidly translated into the clinical practice. Thus, there is an urgent need for proven 
in vitro assays to reduce the burden of animal testing. Unfortunately, the correlation between the 
in vitro and in vivo assessments of biomaterials is surprisingly poor, reinforcing the need for further 
development of relevant in vitro assays [4]. 
Given the dense vascularization of organs and tissues, the first fluid to come in contact with an 
implant is the blood [5], accounting for the formation of the first hydration layer covering the 
implant surface [6]. Examination of the constitution of the adsorbed protein layer and its effect on 
the bone-tissue-implant microenvironment might be crucial in the assessment of the success of an 
implant [7]. The type and characteristics (hydrophobicity, microtopography, chemical properties) 
of the constitutive material of the implant [8] and the first protein layer on the implant surface will 
ultimately determine osseointegration, involving processes like the blood coagulation, 
inflammation, and humoral immune response [9]. Hong et al. have studied the Ti properties in 
terms of its thrombogenic potential; it is one of the metals with high biocompatibility even though 
it lacks the bioactive properties [10]. On the other hand, in previous studies of our group using 
mass spectrometry (LC/MS/MS), we have shown that two different Ti surface treatments, with 
slightly different in vivo behaviour, display variations in the adsorbed first protein layer [11]. These 
studies open up the exciting possibility of predicting the body reaction after implantation. It is 
possible that protein deposition studies might provide in the future a major breakthrough in the 
understanding and prediction of biomaterial behaviour in in vivo environments [12,13]. 
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Our present study focuses on the characterisation of the protein layer adsorbed onto Ti discs 
(blasted and acid-etched) coated with two distinct sol-gel hybrid coating formulations [2,3]; 50% 
methyltrimethoxysilane : 50% 3-glycidoxypropyl-trimethoxysilane (50M50G) and 70% 
methyltrimethoxysilane : 30 % tetraethyl orthosilicate (70M30T) and the correlation between their 
in vitro and in vivo behaviour. Our results show that the biomaterial that induces scar tissue in in 
vivo implants is associated with a distinct map of adsorbed proteins. Most of these proteins are 
related to the immune response, suggesting that this protein layer might be responsible for the 
formation of the fibrous capsules. 
 
b. MATERIALS AND METHODS 
i. Preparation of the coated titanium discs 
Ti discs (12 mm in diameter, 1-mm thick) were made from a bar of commercially available, pure, 
grade-4 Ti (Ilerimplant SL, Lleida, Spain). Sandblasted acid-etched (SAE) Ti discs were abraded with 
4 μm aluminium oxide particles and acid-etched by submersion in sulfuric acid for 1 h, to simulate 
a moderately rough implant surface. The discs were then washed with acetone, ethanol and 18.2 
Ω puriﬁed water (for 20 min in each liquid) in an ultrasonic bath and dried under vacuum. Finally, 
all Ti discs were sterilised using UV radiation. 
 
 
 
 
ii. Sol-gel synthesis and sample preparation 
 The silica hybrid coatings were obtained using the sol-gel route. The synthesised sol-gel 
compounds were 70% MTMOS: 30% TEOS (70M30T) and 50% MTMOS: 50% GPTMS (50M50G) 
(Sigma-Aldrich, St. Louis, MO, USA) (molar percentages). 2-propanol (Sigma-Aldrich, St. Louis, MO, 
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USA) was used as a solvent at a volume ratio of alcohol to siloxane of 1:1. Hydrolysis of 
alkoxysilanes was carried out by adding (at a rate of a drop per second) the corresponding 
stoichiometric amount of acidified aqueous solution 0.1M HNO3 (Panreac, Barcelona, Spain). The 
solution was stirred for 1 h and then left to rest for 1 h. The samples were prepared immediately 
afterwards. SAE Ti discs were used as a substrate. The coating was performed employing a dip 
coater (KSV instrument-KSV DC). Discs were immersed in a sol-gel solution at a speed of 60 cm min-
1, left for one minute, and removed at a 100 cm min-1. Finally, 70M30T- and 50M50G-coated 
samples were cured for 2 h at 80 ºC and 140 ºC, respectively. 
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iii. Preparation of the coated titanium discs 
The contact angle was measured using an automatic contact angle meter (DataPhysics, OCA 20). 
An aliquot of 10 µl of ultra-pure water W04 was deposited on the sol-gel coated surface at a dosing 
rate of 27.5 μl s-1 at room temperature. Contact angles were determined using SCA 20 software. 
Five discs of each material were studied after depositing two drops on each. The surface 
topography of the coatings was characterised by scanning electron microscopy (SEM) using a Leica-
Zeiss LEO equipment under vacuum. Platinum sputtering was applied to make the samples more 
conductive for the SEM observations. 
 
iv.  Cell culture 
 MC3T3-E1 (mouse-calvaria osteosarcoma cell line) cells were cultured on the 70M30T- and 
50M50G-coated Ti discs, at a concentration of 1×104 cells/well. The culture took place in 
Dulbecco’s Modified Eagle’s Medium (DMEM) with phenol red (Thermo Fisher Scientific, Waltham, 
MA, USA), 1% 100× penicillin/streptomycin (Biowest Inc., Riverside, KS, USA) and 10% Fetal Bovine 
Serum (FBS) (Thermo Fisher Scientific, Waltham, MA, USA). After an incubation for 24 h at 37 ºC in 
a humidified (95%) atmosphere of 5% CO2, the medium was replaced with an osteogenic medium 
composed of DMEM with phenol red 1×, 1% penicillin/streptomycin, 10% FBS, 1% ascorbic acid (5 
mg mL-1) and 0.21% β-glycerol phosphate. The cells were incubated again under the same 
conditions. The culture medium was changed every 48 hours. Cells at the same concentration were 
used as a control of culture conditions on each plate. 
 
v.  Cytotoxicity 
The biomaterial cytotoxicity was assessed following the ISO 10993-5 norm, using the 96-cell Titter 
Proliferation Assay (Promega®, Madison, WI, USA) according to manufacturer’s guidelines. Cells 
only (blank well) is considered maximal viability. Cells incubated in latex were the control for highly 
toxic compound. Cell viability of 70% was considered the limit. 
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vi. Alkaline phosphatase (ALP) activity 
The protocol of conversion of p-nitrophenylphosphate (p-NPP) to p-nitrophenol was used to assess 
the ALP activity at the indicated times. Aliquots of 0.1 mL were used to measure the ALP activity. 
One hundred µl of p-NPP (1 mg mL-1) in the substrate buffer (50 mM glycine, 1mM MgCl2, pH 10.5) 
was added to 100 µl of the supernatant obtained from the lysate. After 2 h of incubation in the 
dark (37 ºC, 5% CO2), the absorbance was measured in a microplate reader at a wavelength of 405 
nm. ALP activity was read from a standard curve obtained using different solutions of p-nitrophenol 
and sodium hydroxide (0.02 mM). The results were presented as millimoles of p-nitrophenol/h 
(mmol PNP h-1), and the data were expressed as ALP activity normalised to the total protein content 
(µg µL-1). Protein concentration was quantified using Pierce BCA assay kit (Thermo Fisher Scientific, 
Waltham, MA, USA).  
vii. Statistical analysis 
The data were submitted to one-way analysis of variance (ANOVA) and to a Newman-Keuls 
multiple comparison post-test, when appropriate. Differences with p ≤ 0.05 were considered 
statistically significant. 
 
viii. In vivo experiments 
 To evaluate the histological response to the biomaterials described, the implants were surgically 
placed in the tibia of New Zealand rabbits (Oryctolagus cuniculus). This implantation has been 
widely used in the studies of osseointegration of dental implants [14]. All our experiments were 
performed in accordance with the protocols of Ethical Committee at the University of Murcia 
(Spain), European guidelines and the legal conditions formulated in R. D. 223/1988 of March 14th 
and the Order of October 13rd, 1988, of the Spanish Government law on the protection of animals 
used for experimentation and other scientific purposes. Briefly, 20 rabbits (2-3Kg) were kept under 
12-h span darkness-light cyclic conditions; room temperature was set at 20.5 ± 0.5 °C and the 
relative humidity ranged between 45 and 65%. The animals were individually caged and fed a 
standard diet and filtered water ad libitum. The dental implants were supplied by Ilerimplant SL 
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(Lleida, Spain). The implants were internal-connection made with Ti grade IV, trademark GMI 
dental implants, 3.75 mm in diameter, 8-mm long, Frontier model with ADS (Advanced Doubled-
Grip Surface) treatment, a combination of white corundum micro-bubble treatment and acid 
etching with nitric acid and sulfuric acid solution. 40 implants were used, 20 uncoated as controls, 
and 5 coated as test samples for each material and each time. 5 rabbits were used for each material 
and time. The implantation periods of the experimental model were 4 and 8 weeks. Implants were 
inserted in the left and right proximal tibiae (one control and one test sample). Animals were 
anesthetized with chlorpromazine hydrochloride and ketamine chlorhydrate. The periosteum was 
removed, and the osteotomy was performed using a low-revolution micromotor and drills of 
successive diameters of 2, 2.8 and 3.2 mm, with continuous irrigation. Implants were inserted and 
press-fit and the surgical wound was sutured, washed with saline solution and covered with plastic 
spray dressing (Nobecutan, Inibsa Laboratories, Barcelona, Spain). After each examined 
implantation period, the animal was euthanized by carbon monoxide inhalation, to retrieve the 
screws and study the surrounding tissues. 
 
ix. Histological examination and quantification 
Four samples for histological examination were processed following the methodology described 
previously [2]. Briefly, the samples were embedded in methyl methacrylate, and 25–30 µm 
sections were obtained using EXAKT technique (EXAKT Technologies, Inc., Oklahoma, USA). For 
optical microscopy examination, all the sections were stained using Gomori Trichrome solution. 
Fibrous connective tissue was quantified using ImageJ software (https://imagej.nih.gov/ij/).  The 
results are expressed as the estimate area occupied by fibrous connective tissue per area in mm2.  
 
x. Adsorbed protein layer 
Ti discs coated with 70M30T (n = 4) and 50M50G (n = 4) were incubated in a 24-well plate for 180 
min in a humidified atmosphere (37 ºC, 5% CO2), after the addition of 2 mL of human blood serum 
from male AB plasma (Sigma-Aldrich, St. Louis, MO, USA). After removing the serum, to remove 
the remaining non-adhered proteins, the discs were rinsed five times with ddH2O and once with 
100 mM NaCl, 50 mM Tris-HCl, pH 7.0. The adsorbed protein layer was collected by washing the 
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discs in the solution of 4% SDS, 100 mM DTT and 0.5M TEAB. The experimental method was 
adapted from a previous study by Kaneko et al. [12]. Four replicates of each biomaterial were 
obtained. Total protein content was quantified before the experiment (Pierce BCA assay kit 
(Thermo Fisher Scientific, Waltham, MA, USA)), obtaining the value of 51 mg mL-1. 
xi. Proteomic analysis 
The eluted protein samples were resolved on 10% polyacrylamide gels, using a Mini-Protean II 
electrophoresis cell (Bio-Rad®, Hercules, CA, USA). A constant voltage of 150 V was applied for 45 
min. The gel was then stained using SYPRO Ruby stain (Bio-Rad®, Hercules, CA, USA) following the 
manufacturer’s instructions. The gel was washed, and each lane was cut into 4 slices. Each of these 
slices was digested with trypsin following a standard protocol [15]. The resulting peptides were 
resuspended in 0.1% formic acid, separated using online NanoLC and analysed using electrospray 
tandem mass spectrometry. Peptide separation was performed on a nanoACQUITY UPLC system 
(Waters, Milford, MA, USA) connected to a SYNAPT G2-Si spectrometer (Waters, Milford, MA, USA) 
Samples were loaded onto a Symmetry 300 C18 UPLC Trap column   with 5 μm, 180 μm × 20 mm 
connected to a BEH130 C18 column with 1.7 μm, 75 μm × 200 mm (Waters, Milford, MA, USA). The 
column was equilibrated in 3% acetonitrile and 0.1% FA. Peptides were eluted at 300 nl min-1 using 
a 60-min linear gradient of 3−50% acetonitrile. 
 A SYNAPT G2-Si ESI Q-Mobility-TOF spectrometer (Waters, Milford, MA, USA) equipped with an 
ion mobility chamber (T-Wave-IMS) for high definition data acquisition analyses was used for the 
analysis of the peptides. All analyses were performed using electrospray ionization (ESI) in a 
positive ion mode. Data were post-acquisition lock-mass corrected using the double charged 
monoisotopic ion of [Glu1]-fibrinopeptide B. The accurate LC-MS data were collected in HDDA 
mode, which enhances the signal intensities using the ion mobility separation. 
Progenesis LC-MS software (Nonlinear Dynamics, Newcastle, UK) was used for differential protein 
expression analysis. Raw files were imported into the programme, and one of the samples was 
selected for a reference run to which the precursor masses in all the other samples were aligned. 
Abundance ratio between the run to be aligned and the reference run were calculated for all 
features at given retention times. These values were then logarithmised and the programme, 
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based on the analysis of the distribution of all ratios, automatically calculated a global scaling factor. 
Once normalised, the samples were grouped into the appropriate experimental categories and 
compared. A peak list containing the detected peptides in all samples was searched against the 
Swiss-Prot database using the Mascot Search engine (www.matrixscience.com). Peptide mass 
tolerance of 10 ppm and 0.2-Da fragment mass tolerance were used for the searches. 
Carbamidomethylation of cysteines was selected as the fixed modification and oxidation of 
methionine as a variable modification for tryptic peptides. Proteins identified with at least two 
peptides with an FDR < 1% were kept for further examination. Proteins were quantified based on 
the intensity of their 3 most abundant peptides, when available. Proteins with ANOVA p < 0.05 and 
a ratio higher than 1.3 in either direction was considered as significantly different. 
Finally, the data were entered in the Database for Annotation, Visualization and Integrated 
Discovery (DAVID) Bioinformatics Resources to classify the Progenesis differential protein list into 
functionally related clusters. 
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c. RESULTS  
i. Synthesis and physicochemical characterisation 
 The synthesis conditions described here allowed us to obtain the different coatings. SEM 
micrographs of 70M30T (Figure 1a) and 50M50G (Figure 1b) coatings show distinct topographies. 
70M30T surface conserves the SAE-Ti roughness properties and is rougher than the 50M50G 
surface. In the latter, the initial SAE-Ti irregularities are covered, possibly due to an increased 
thickness. The contact angle measurements gave values of 50.78 ± 1.82º and 67.59 ± 1.03º for 
70M30T and 50M50G coatings, respectively. These data indicate that the 70M30T biomaterial is 
more hydrophilic than 50M50G. 
 
Figure 1. SEM images of sol–gel coated disc surface. 70M30T (a) and 50M50G (b). Calibration bar 10 mm. 
ii. In vitro culture 
 Neither of the materials was cytotoxic (Figure 2a). The mineralisation analysis, performed by 
measuring ALP activity, showed that in vitro, 70M30T and 50M50G did not affect the osteoblast 
cell differentiation significantly, at 7 and 14 days (Figure 2b). The two biomaterials behaved 
similarly in terms of the metabolic and differentiation processes of MC3T3-E1 cells in vitro. 
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Figure 2. MC3T3-E1 cell viability and mineralization in vitro. Percentage of cell survival following the norm ISO 
10993–5 (a). ALP activity (mM PNP/h) normalized to the protein concentration (mg/mL) of cells grown without 
disc (oblicue lines), grown on control Ti discs (horizontal lines), 70M30G (white column) and 50M50G coated 
Ti discs (black column). 
 
iii. In vivo assay 
 Four and eight weeks after the implantation, some differences between the materials were 
observed (Figure 3a). Whereas 70M30T-coated screws displayed good osseointegration on the 
implant-cortical bone interface, the 50M50G-coated implants were surrounded by a thick fibrous 
capsule. This result is support by the graph on Figure 3b displaying that the area occupied by 
fibrous connective tissue is approximately 4-fold higher on the 50M50G material, compared to the 
70M30T, for both times. In light of these results, we can conclude that 50M50G-coated implants 
provoked an immune/inflammatory response, which might prevent implant integration, bone 
formation and ultimately cause the implant rejection. 
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Figure 3. In vivo studies. Light microscopy images (EXAKT® cut and Gomori Trichrome stain) from in vivo 
implants 4 and 8 weeks postimplantation of Control-Ti, 70M30T and 50M50G sol–gel coated screw; (a) 
Calibration bar 500 mm; (b) Calibration bar 100 mm. (c) Quantification fibrous of the connective tissue area 
(n=4). Significant values were considered for p<0.05 as analysed by ANOVA followed by Newman-Keuls post-
test. 
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iv. Proteomic analysis 
The protein layers absorbed onto 70M30T and 50M50G coatings were analysed by LC-MS/MS, 
which identified 171 different proteins. The data were also analysed (n = 4) using the Progenesis 
QI software, to find out which proteins were differentially predominant on the two materials. 
Moreover, the DAVID was used to obtain a functional classification of the proteins. Table I shows 
eight enriched proteins identified in the 70M30T film. Keratins, hornerin, filaggrin-2 and 
tropomyosin alpha-3 chain were substantially more abundant on this material. All these proteins 
are related to peptidase activity and/or the integrity of the cytoskeleton.   
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Table I. LC-MS/MS Detected Proteins Differentially Predominant in the Film Adsorbed to the 70M30T Sol–Gel 
Biomaterial (Progenesis Method) 
Description 
Ratio 
50M50G/70M30T 
Ref. bone metabolism 
or/and immune response 
DAVID 
Tropomyosin alpha-3 chain 0,06 - 9 
Filaggrin-2 0,35 - 5,8 
Hornerin 0,40 - 5,8,9 
Keratin, type II cytoskeletal 1b 0,49 - 9 
Keratin, type II cytoskeletal 71 0,51 - 9 
Keratin, type II cytoskeletal 78 0,60 - 9 
Keratin, type I cytoskeletal 10 0,61 - 9 
Keratin, type II cytoskeletal 2 
epidermal 
0,63 - 9 
The averages are the result of 4 independent replicates. Differences were considered significant with an ANOVA p values<0.05. DAVID 
classification functions were inflammatory/immune response (1), hydroxylation (2), blood coagulation (3), apoptosis regulation (4), metal 
binding (5), phosphorylation (6), carbohydrate binding (7), peptidase activity (8), and cytoskeleton integrity (9).  
 
However, 30 serum proteins adhered differentially to the 50M50G material (Table II). Proteins 
related to tissue regeneration and bone metabolism such as plasminogen [16,17], proteoglycan 4 
[18], vitronectin [19], Apo E [20,21], kininogen-1 [22] and complement C3 [24–26] were more 
abundant on that coating. Increased amounts of many proteins related to the immune system and 
inflammatory response were also found on this material. Complement C1r subcomponent, 
complement factor H, C4b-binding protein alpha chain, C-reactive protein, complement C3, 
complement C5, complement component C7, serum amyloid P-component, complement C1q 
subcomponent subunits A, B and C, complement C1s subcomponent and plasma protease C1 
inhibitor proteins were found and classified by DAVID database analysis  belonging to a protein 
cluster related to an acute inflammatory response. 
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Table II. LC-MS/MS detected proteins differentially predominant in the film adsorbed to the 50M50G sol-gel 
biomaterial (Progenesis method). The averages are the result of 4 independent replicates. Differences were 
considered significant with an ANOVA p-value < 0.05. DAVID classification functions were 
inflammatory/immune response (1), hydroxylation (2), blood coagulation (3), apoptosis regulation (4), metal 
binding (5), phosphorylation (6), carbohydrate binding (7), peptidase activity (8) and cytoskeleton integrity 
(9). (Table continues next page) 
Description 
Ratio 
50M50G/ 
70M30T 
Ref. bone metabolism or/and 
immune response 
DAVID 
Complement C1r subcomponent 1,38 [41] 1,2,5,8 
Plasminogen 1,49 [16,17] 3,4,5,8 
Ig kappa chain V-II region Cum 1,63 - - 
Apolipoprotein A-IV 1,67 - 5 
Hemopexin 1,70 [45] 5,6 
Ig lambda-2 chain C regions 1,73 - - 
Proteoglycan 4 1,79 [18] 7 
Complement factor H 1,82 [41] 1 
Ig kappa chain V-III region VG (Fragment) 1,90 - - 
Ig kappa chain V-III region SIE 1,93 - - 
Kininogen-1 2,02 [28] 
1,2,3,4,5,
7 
C4b-binding protein alpha chain 2,06 [41] 1 
Complement C1s subcomponent 2,07 [41] 1,2,5,8 
Ig kappa chain V-IV region Len 2,08 - - 
Vitronectin 2,21 [19] 7 
Complement component C7 2,22 [41] 1 
Complement C1q subcomponent subunit B 2,24 [41] 1,2 
Complement C1q subcomponent subunit C 2,26 [41] 1,2 
Complement C3 2,27 [23;24] 1 
Plasma protease C1 inhibitor 2,34 [44] 1,3 
Apolipoprotein E 2,40 [20;21] 3,4,5,6,7 
Leucine-rich alpha-2-glycoprotein 2,54 [42] 5 
Complement C5 2,55 [41] 1,6 
Serum amyloid P-component 3,48 [43] 1,5,7,8 
Complement C1q subcomponent subunit A 3,60 [41] 1,2 
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d. DISCUSSION 
This study focused on the characterisation of the protein layer adsorbed onto the Ti discs (blasted 
and acid-etched) coated with two distinct biomaterials, 70MTMOS:30TEOS (70M30T) and 
50MTMOS:50GPTMS (50M50G). Moreover, it was analysed the correlation between their in vitro 
and in vivo behaviour. The application of these biomaterials onto the disc surfaces changed the 
biological and physicochemical properties of Ti. 
Distinct precursors were used to synthesise the two coatings. Both materials are composed by 
MTMOS, being the main chemical difference between them the presence of TEOS and GPTMS. 
GPTMS is an organo-modified alkoxysilane with an epoxy group. In contrast, the TEOS does not 
possess that group [25]. The more pronounced organic features of 50M50G sol-gel matrix increase 
the hydrophobic properties of this material, reflected in the contact angle results. These 
differences in the chemical, hydrophilic and morphologic characteristics might affect the response 
and behaviour of the material in a biological context. However, in vitro experiments show no 
significant differences between the two types of coated discs. Both materials were found to be 
non-cytotoxic or/and even did influence nor positively nor negatively the ALP activity compared to 
non-coated SLA titanium. Nonetheless, it was observed drastic differences between the in vivo 
behaviour of these coatings. Our results showed the formation a layer of fibrous connective tissue 
surrounding the 50M50G, between the bone and the implant, which was not found on the 70M30T 
surface. 
Description 
Ratio 
50M50G/ 
70M30T 
Ref. bone metabolism or/and 
immune response 
DAVID 
Myosin-1 4,22 - 9 
Lipocalin-1 4,28 - 8 
C-reactive protein 7,83 [31] 1,5,8 
Glutamate dehydrogenase 1, mitochondrial 13,47 - - 
L-lactate dehydrogenase B chain 14,30 - - 
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Although there is a considerable need for proven in vitro assays to reduce the burden of animal 
testing, a recent multicentre review has shown no significant overall correlation between the in 
vitro and in vivo effects of biomaterials used for bone regeneration. The inadequacies of the 
current in vitro assessments highlight the urgent need for novel approaches to the in vitro 
biomaterial testing and the lack of validated pre-clinical studies [4].  
Proteomic analysis using LC/MS-MS identified and quantified the proteins adsorbed onto the two 
surfaces (Tables I and II). The results displayed a distinct cluster of proteins, closely related to the 
immune and/or inflammatory response, predominant on the 50M50G biomaterial (in comparison 
with 70M30T). This observation might explain the in vivo outcome. The formation of a fibrous 
connective tissue in in vivo experiments has been reported and attributed to the natural immune 
and inflammatory response to a foreign body [26,27] The increased abundance of bone 
regeneration/repair-related proteins like plasminogen [16,17], proteoglycan 4 [18], vitronectin 
[19], Apo E [20,21] and kininogen-1 [28,29] observed on the 50M50G-coated implants might be 
required for osseointegration. Interestingly, it was also found increased levels of proteins of the 
classical complement system on this material in comparison with the 70M30T coating. The 
complement system plays a crucial role in an immediate immune response to the pathogens [30]. 
We are prone to speculate that the first layer of the proteins adsorbed onto the surface induces a 
fast-immune response. This response might be induced by the increased levels (7-fold) of CRP (C-
reactive protein), a protein with an important role in the immune response pathways [31,32]. CRP 
is a well-documented risk factor for cardiac diseases [32]. It belongs to a family of serum proteins 
with a pentameric structure, pentraxins, which can recognize antigens, activate the immune 
system (e.g. immunoglobulins), and interact with the complement system. In fact, one of the first 
reported CRP functions is its ability to trigger the whole classical complement system [33]. It acts 
by direct binding of the C1q, the first component of this system; C1q levels were also augmented 
on the 50M50G coating (2-fold). The binding of C1q to CRP activates a cascade of complements. 
C1r and C1s are activated, activating C4 and C2 in turn, followed by the generation of C3 
convertases. The C3 convertases cleave C3 into C3a and C3b. C3a has both pro- and anti-
inflammatory effects. C3b functions as an opsonin and activates the cleavage of C5 into 
anaphylatoxins C5a and C5b, ultimately forming the C5b-9 complex [34]. Both C3a and C5b are 
responsible for the recruitment and activation of the immune cells, such as macrophages, to the 
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activation site [35]. The complement-activated macrophages regulate fibrogenesis by promoting 
the cytokine activity and cell migration, resulting in the fibroblast proliferation and collagen 
synthesis[36]. Specifically, they act by secreting pro-fibrogenic factors, increasing fibrogenesis by 
fibroblasts and inducing the formation and development of the fibrous capsule around the 
implanted material. The thickness of the formed fibrous capsule can interfere with the function of 
the biomaterial, depending on the intensity of the immune/inflammatory response [37].  
Thus, it is tempting to correlate the presence of these proteins with the in vivo response observed 
in this experimental work. Other authors have discussed the possibility of this binomial behaviour. 
Ekdahl et al. have reported that the binding of C3 protein on the surface of biomaterials might be 
negatively correlated with their biocompatibility [38]. Similarly, Engberg et al. have stablished a 
correlation between the absorption of proteins such as C3, C4, C5, C1q, factor H or C4BP and the 
inflammatory response induced by biomaterials. They have proposed the high C4/C4BP protein 
ratio as a predictor of low biocompatibility [39]. These studies have been carried out by pre-
selecting the proteins to be detected. However, we believe that the proteomics methodology used 
in our study may improve our understanding of the role of proteins in the osseointegration 
processes. The results shown in Table II link the formation of the fibrous capsule with the cluster 
of proteins related to an acute inflammatory response. The presence of CRP within this cluster 
might be important in the activation of the immune reaction. Thus, within the limitations of this 
study, CRP might be proposed as a marker of poor biocompatibility, if it is found on the biomaterial 
surfaces at substantially increased levels. 
However, we found intracellular proteins adhered to the biomaterial surface. This ﬁnding may be 
a consequence of the plasma isolation process, where cellular breakdown might occur. The 
presence of such proteins may or may not inﬂuence the biomaterial in vivo outcome, since these 
proteins should be mostly expressed intracellularly. It is generally accepted that intra-cellular and 
membrane proteins or fragments are commonly found serum and plasma [40]. We cannot exclude 
a possible cellular breakdown in vivo, even as a consequence of the surgery itself. 
To summarise, we found that surfaces with distinct physico-chemical properties, such as 70M30T 
and 50M50G sol-gel coatings, could produce different in vivo responses. These responses might 
depend on the bodily fluids (serum/blood) in contact with the implant surface. We showed that 
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the majority of the specific serum proteins adhering to the 50M50G biomaterial belong to a cluster 
of proteins related to the immune/inflammatory response. Thus, it is plausible that the fibrous 
connective tissue surrounding the 50M50G material might be the consequence of the adsorption 
of various complement system proteins. The increased abundance of CRP, one of these proteins, 
might significantly affect the success of osseointegration. 
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ABSTRACT  
The prime objective in the development of biomaterials for dental applications are to improve the 
quality of osseointegration and to short the time needed to achieve it. Design of implants 
nowadays involve changes in the surface characteristics to obtain a good cellular response. 
Incorporating osteoinductive elements is one way to achieve the best regeneration possible post-
implantation. This study examined the osteointegrative potential of two distinct biomaterials: 
sandblasted acid-etched titanium and a silica sol-gel hybrid coating, 70% MTMOS-30% TEOS. In 
vitro, in vivo and proteomic characterisation of the two materials were conducted. Enhanced 
expression levels of ALP and IL-6 in the MC3T3-E1 cells cultured with coated discs, suggest that 
growing cells on such surfaces may increase mineralisation levels. 70M30T-coated implants, 
showed improved bone growth in vivo compared to uncoated titanium. Complete osseointegration 
was achieved on both. However, coated implants displayed osteoinductive properties, while 
uncoated implants demonstrated osteoconductive characteristics.  Coagulation-related proteins 
attached predominantly to SAE-Ti surface. Surface properties of the material might drive the 
regenerative process of the affected tissue. Analysis of the proteins on the coated dental implant 
showed that few proteins specifically attached to its surface, possibly indicating that its 
osteoinductive properties depend on the silicon delivery from the implant. 
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a. INTRODUCTION 
 Osseous tissue undergoes continuous remodelling, which depends on the balance between the 
activities of highly specialised cells, the osteoblasts and osteoclasts. This balance is adaptive; the 
system responds to mechanical stresses and is affected by the processes involved in the 
maintenance of bone health and bone regeneration [1]. 
The terms osteoinduction and osteoconduction are often used in the field of orthopaedics. They 
are commonly discussed in dental implantology practice, where various implants have been 
employed with long-term success rates of around 95% [2]. As the demand for this type of 
treatment is growing and the number of such surgeries is increasing, even these high rates seem 
to be insufficient. New surface types specifically designed for dental implants could improve the 
success ratios. They should also achieve better and faster osseointegration than the traditional 
materials [3]. This is especially important in cases with compromised bone regeneration capability 
(e.g. smokers, osteoporotic and diabetic patients, etc.). 
Osteoinduction (the process by which osteogenesis is induced) involves stimulation of 
undifferentiated cells, resulting in the development of bone-forming cell lineage [4]. 
Osteoconduction is the property of a material serving as a scaffold for the growth of bone tissue. 
The osteoconductive potential of a surface is affected by its roughness, microtopography, 
nanotopography and porosity [5]. These two processes (osteoinduction and osteoconduction) are 
important for osseointegration, i.e. a direct structural and functional connection between the 
newly formed bone and the biomaterial [6]. 
The clinical success of a dental implant strongly depends on a short-term osseointegration. Good 
osseointegration rate of the titanium dental implants is necessary for a successful early clinical 
outcome [7]. Such implants, apart from supporting the correct healthy bone integration, should 
promote the activation of osteoblasts in the impaired tissue, stimulating the osteogenesis. This 
should facilitate surgical implantations in patients with regenerative limitations. 
Thus, the design of new dental implants should consider both chemical and physical surface 
modifications. Such modifications affect surface implant topography, hydrophobicity and the 
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chemical properties of the implant material (and especially, of its surface). The purpose is to 
enhance the biological interaction of the living tissue with the material [8]. 
The sol-gel hybrid materials synthesised using alkoxysilanes are being increasingly used as coatings 
for biomedical applications. They are being  developed as coatings for titanium dental implants 
[9,10]. These biomaterials release silicic acid compounds (Si(OH)4), which impart osteoinductive 
properties to the implant [11,12]. 
The application of these coatings onto an implant surface affects its physical and chemical 
attributes, and, consequently, alters the conformation, type and quantity of proteins adsorbed 
immediately after implantation [13]. These are the proteins that might determine the initiation 
and intensity of the immune and inflammatory response and coagulation [14] and activate 
processes triggering osteogenesis, leading to effective osseointegration. Thus, the studies of the 
adsorbed proteins are of primary importance for the orthopaedics and other associated medical 
fields. Such studies should contribute to new insights into the mechanisms governing the 
microenvironment of the protein–biomaterial surface interactions. 
This article presents in vitro, in vivo and proteomic characaterisation of two different surfaces type 
(SAE-Ti, and sol-gel coating). The bone regeneration mechanism and potential of the two surfaces 
are studied and compared. 
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b. MATERIALS AND METHODS 
i. Preparation of the titanium discs 
 Ti discs (12 mm in diameter, 1-mm thick) were made from a bar of commercially available, pure, 
grade-4 Ti (Ilerimplant S.L., Lleida, Spain). To obtain the sandblasted, acid-etched (SAE) Ti, the discs 
were abraded with 4-μm aluminium oxide particles and acid-etched by submersion in sulfuric acid 
for 1 h, to simulate a moderately rough implant surface. The discs were then washed with acetone, 
ethanol and 18.2-Ω puriﬁed water (for 20 min in each liquid) in an ultrasonic bath and dried under 
vacuum. Finally, all Ti discs were sterilised using UV radiation. 
 
ii.  Sol-gel synthesis and sample preparation 
 The silica hybrid sol-gel material was synthesised from the alkoxysilane precursors: 
methyltrimethoxysilane (MTMOS) and tetraethyl orthosilicate (TEOS) (Sigma-Aldrich, St. Louis, 
MO, USA) in molar percentages of 70% and 30%, respectively. This composition was adopted on 
the basis of the previous results [9]. 
2-Propanol (Sigma-Aldrich, St. Louis, MO, USA) was used as a solvent in the process at a volume 
ratio (alcohol:siloxane) of 1:1. Hydrolysis of alkoxysilanes was carried out by adding (at a rate of 1 
drop. s-1) the corresponding stoichiometric amount of 0.1 M aqueous solution of HNO3 (Panreac, 
Barcelona, Spain). The mixture was kept for 1 h under stirring followed by 1 h at rest. Coated 
samples were prepared immediately afterwards with SAE-Ti as a substrate. The samples were 
coated employing a KSV DC dip coater (Biolin Scientific, Stockholm, Sweden). Discs and implants 
were immersed in the sol-gel solution at a speed of 60 cm.min-1, left immersed for one minute, 
and removed at a 100 cm.min-1. Finally, the samples were cured for 2 h at 80 ºC. 
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iii. Physico-chemical characterisation of the coated titanium discs 
The surface topography of samples was examined by scanning electron microscopy (SEM), 
employing the Leica-Zeiss LEO equipment under vacuum (Leica, Wetzlar, Germany). Platinum 
sputtering was applied to make the materials more conductive. A mechanical profilometer Dektack 
6M (Veeco Instruments, Plainview, NY, USA) was used to assess the material roughness. Two 
coated discs of each composition were tested. Three measurements were performed for each disc 
to obtain the average values of the Ra parameter. The contact angle was measured using an 
automatic contact angle meter OCA 20 (DataPhysics Instruments, Filderstadt, Germany). Aliquots 
of 10 µL of ultrapure water W04 were deposited on the disc surfaces at a dosing rate of 27.5 μL. s-
1 at room temperature. Contact angles were determined using the SCA 20 software. Six discs of 
each material were studied, after depositing two drops on each disc. 
 
iv. In vitro assays 
1.1. Cell culture  
Mouse calvaria osteosarcoma cells (MC3T3-E1) were cultured on the sol-gel coated titanium discs 
at a concentration of 1 × 104 cells/well. The cells were grown in Dulbecco’s modified Eagle’s 
medium (DMEM) with phenol red (Gibco-Life Technologies, Grand Island, NY, USA), 1% 
penicillin/streptomycin solution 100× (Biowest Inc., Riverside, KS, USA) and 10% fetal bovine serum 
(FBS) (Gibco-Life Technologies). After incubation for 24 hours at 37 ºC in a humidified (95%) 
atmosphere with 5% CO2, the medium was replaced with an osteogenic medium composed of 
DMEM with phenol red 1×, 1% penicillin/streptomycin, 10% FBS, 1% ascorbic acid (5 mg mL-1) 
(Sigma-Aldrich) and 0.21% β-glycerol phosphate (Sigma-Aldrich), and incubated again under the 
same conditions. The culture medium was changed every 48 hours. In each plate, an empty well 
with cells at the same concentration (1 × 104 cells), was used as a control of culture conditions. For 
RNA isolation, the cells were allowed to differentiate for 7 and 14 before being harvested. 
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1.2. Cytotoxicity 
 The biomaterial cytotoxicity was evaluated following the ISO 10993-5 norm; it was assessed using 
spectrophotometry, after incubation of the cells with the material extract, obtained after following 
the norm. The CellTiter 96 Proliferation Assay (Promega®, Madison, WI, USA) was employed to 
measure cell viability after 24 h incubation. We used a negative control (the empty cell well) and a 
positive control with latex, known to be toxic to the cells. Seventy-percent cell viability was the 
limit below which a biomaterial was considered cytotoxic. 
 
1.3. Cell proliferation 
For measuring cell proliferation, the commercial cell-viability assay alamarBlue® (Invitrogen-
Thermo Fisher Scientific, Waltham, MA, USA) was used. The kit measures the cell viability on the 
basis of a redox reaction with resazurin. The cells were cultured in wells with the discs (3 replicates 
per treatment) and examined following the manufacturer’s protocol after 1, 3, 5 and 7 days of 
culture. The results (percentage of reduced resazurin) were used to evaluate cell proliferation. 
 
 
1.4. Alcaline Phosphatase (ALP) activity 
The conversion of p-nitrophenylphosphate (p-NPP) to p-nitrophenol was used to assess the activity. 
The culture medium was removed from the wells, which were then washed 3 times with 1 × DPBS 
(Dulbeccos’ phosphate-buffered saline- Thermofisher Scientific), and 100 µL of lysis buffer (0. 2% 
Triton X-100, 10 mM Tris-HCl, pH 7.2) (Sigma-Aldrich) was added to each well. Sample aliquots of 
0.1 mL were used to conduct the assay. One hundred µL of p-NPP (1 mg mL-1) in substrate buffer 
(50 mM glycine, 1mM MgCl2, pH 10.5) was added to 100 µL of the supernatant obtained from the 
lysate. After two hours of incubation in the dark (37 ºC, 5% CO2), the absorbance was measured, 
using a microplate reader, at a wavelength of 405 nm. ALP activity was read from a standard curve 
obtained using different solutions of p-nitrophenol and 0.02 mM sodium hydroxide (Sigma-Aldrich). 
The results were presented as mmol of p-nitrophenol/hour (mmol PNP h-1). The data were 
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expressed as ALP activity normalised to the total protein content (µg.µL-1) obtained using Pierce 
BCA assay kit (Thermo Fisher Scientific, Waltham, MA, USA) after 7 and 14 days of culture. 
 
1.5. RNA isolation and cDNA synthesis 
 Total RNA was prepared from the cell lysates grown on the sol-gel coated titanium discs, using 
Qiagen RNeasy Mini kit (Hilden, Germany), following digestion with DNase I (Qiagen), according to 
the manufacturer’s instructions. The quantity, integrity and quality of the resulting RNA were 
assessed using NanoVue® Plus Spectrophotometer (GE Healthcare Life Sciences, Little Chalfont, 
United Kingdom). For each sample, approximately 1 µg of total RNA was converted to cDNA using 
PrimeScript RT Reagent Kit (Perfect Real Time) (TAKARA Bio Inc., Shiga, Japan). The resulting cDNA 
was diluted in DNAse-free water to a concentration suitable for reliable RT-PCR analysis. 
 
1.6. Quantitative real-time PCR  
Before the qRT-PCR reaction, primers for ALP, IL6, Col I and OCN genes were designed from specific 
DNA sequences available from NCBI (https://www.ncbi.nlm.nih.gov/nuccore), using PRIMER3plus 
software tool (http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi). Expression 
levels were measured using primers purchased from Life Technologies S.A. (Gaithersburg, MD); 
GADPH sense, TGCCCCCATGTTTGTGATG; GADPH antisense, TGGTGGTGCAGGATGCATT; alkaline 
phosphatase sense, CCAGCAGGTTTCTCTCTTGG; alkaline phosphatase antisense, 
CTGGGAGTCTCATCCTGAGC; IL6 sense, AGTTGCCTTCTTGGGACTGA; IL6 antisense, 
TCCACGATTTCCCAGAGAAC; COLIAI sense, CCTGGTAAAGATGGTGCC; COLI antisense, 
CACCAGGTTCACCTTTCGCACC; OCN sense, GAACAGACTCCGGCGCTA and OCN antisense, 
AGGGAGGATCAAGTCCCG. All primers are listed from 5´ to 3´. GADPH was used as a housekeeping 
gene to normalise the data obtained from the qRT-PCR and calculate the relative fold change 
between the conditions. qPCR reactions were carried out using SYBR Premix Ex Taq (Tli RNase H 
Plus) (TAKARA), in a StepOne Plus™ Real-Time PCR System (Applied Biosystems, Foster City, 
California, USA). The cycling parameters were as follows: an initial denaturation step at 95 ºC for 
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30 s; followed by 95ºC for 5s and 60 ºC for 34 s for a total of 40 cycles. The final melt curve stage 
comprised a cycle of 95 ºC for 15 s and 60 ºC for 60 s. 
 
1.7. Statistical analysis  
 Data were submitted to one-way analysis of variance (ANOVA) and to a Newman-Keuls multiple 
comparison post-test, when appropriate. Differences with p ≤ 0.05 were considered statistically 
significant. 
 
1.8. In vivo experimentation 
The in vivo procedures and histological evaluation of the two tested materials, SAE-Ti and 70M30T, 
were carried out using the previously described methods [9], with the tibia of New Zealand rabbits 
(Oryctolagus cuniculus) as the experimental model. All the experiments were conducted in 
accordance with the protocols of Ethical Committee of the Valencia Polytechnic University (Spain), 
the European guidelines and legal conditions in R. D. 223/1988 of March 14th, and the Order of 
October 13th, 1988 of the Spanish Government on the protection of animals used for 
experimentation and other scientific purposes. Briefly, the dental implants, supplied by Ilerimplant 
S.L. (Lleida, Spain), were the Frontier model (3.75-mm diameter and 8-mm length) with SAE surface 
treatment. Twenty implants were used, 10 uncoated (SAE-Ti) and 10, coated (70M30T). The 
implantation periods of the experimental model were 2 and 4 weeks. Five rabbits were used for 
each material; the implants were inserted into the tibiae of the animals. The samples for 
histological examination were embedded in methyl methacrylate using EXAKT technique (EXAKT 
Technologies, Inc., Oklahoma, USA). For optical microscopy examination, all the sections were 
stained using Gomori Trichrome solution. 
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1.9. Adsorbed protein layer 
 Both 70M30T-coated and uncoated SAE titanium discs were incubated in a 24-well plate for 180 
min in a humidified atmosphere (37 ºC, 5% CO2), after the addition of 1 mL of human blood serum 
from male AB plasma (Sigma-Aldrich, St. Louis, MO, USA). 
The serum was removed, and, to eliminate the non-adsorbed proteins, the discs were rinsed five 
times with ddH2O and once with 100 mM NaCl, 50 mM Tris-HCl, pH 7.0. The adsorbed protein layer 
was collected by washing the discs in 0.5 M triethylammonium bicarbonate buffer (TEAB) with 4% 
of sodium dodecyl sulphate and 100 mM dithiothreitol (Sigma-Aldrich). Four independent 
experiments were carried out for each coating (n = 4); in each experiment, each elution was 
obtained from the incubation of serum of four discs, for each formulation. The protein content was 
quantified (Pierce BCA assay kit; Thermo Fisher Scientific), obtaining a value of 51 mg mL-1. 
 
1.10. Proteomic analysis 
Proteomic analysis was performed as described by Romero-Gavilán et al. [15], with minor 
variations. Briefly, the eluted protein was resolved in polyacrylamide gels; then, the bands were 
cut out. Each of the slices was digested with trypsin and loaded onto a nanoACQUITY UPLC system 
connected online to a SYNAPT G2-Si MS System (Waters, Milford, MA, USA). Each material was 
analysed in quadruplicate. Differential protein analysis was carried out using Progenesis software 
(Nonlinear Dynamics, Newcastle, UK) as described before [15]. The functional annotation of the 
proteins was performed using PANTHER (http://www.pantherdb.org) and DAVID Go annotation 
programmes (https://david.ncifcrf.gov/).  
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c. RESULTS 
 
i. Synthesis and physicochemical characterisation 
 SEM micrographs (Figure 1) demonstrated that the sol-gel preparation was carried out correctly 
and a homogenous coating was obtained. Some morphological differences between the SAE-Ti 
surfaces and 70M30T coatings were observed; the initial SAE-Ti roughness was diminished after 
coating. The Ra, measured using a mechanical profilometer, was lower for the coated samples. The 
Ra for SAE-Ti was 0.98 ± 0.09 µm and for 70M30T sol-gel coating, 0.87 ± 0.13 µm. The sol-gel 
treatment also caused a decrease in the contact angle. The angle was 79.55 ± 7.51º for SAE-Ti and 
50.78 ± 1.82º for 70M30T, showing a significant increase in hydrophilicity after coating. 
 
Figure 1. SEM micrographs of SAE-Ti surfaces and 70M30T sol-gel coating. Calibration bar, 10 µm. 
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ii. In vitro assays 
 
1.1. Cytotoxicity, proliferation and ALP activity 
 Neither of the tested materials was cytotoxic (data not shown). Cell proliferation results did not 
show significant differences between the tested materials (Figure 2A). There were no differences 
between ALP activities for the two materials after 7 and 14 days of incubation (Figure 2B). 
 
Figure 2. MC3T3-E1 in vitro assays: A) MC3T3-E1 cell proliferation after 1, 3, 5 and 7 days of incubation with 
SAE-Ti (white bar) and 70M30T (grey bar) materials. B) ALP activity (mM PNP h-1) normalised to the amount 
of total protein (µg µL-1) levels in the MC3T3-E1 cells cultivated on SAE-Ti (white bar) and 70M30T formulation 
(grey bar). Cells incubated without discs were used as a positive control (black bar). 
 
1.2. mRNA expression levels 
 The mRNA expression levels for ALP and IL-6 genes show a distinctive and significant 
response of the osteoblasts to the coating. After 14 days of culture, the expression of 
these genes was substantially higher for the cells grown on the coated surfaces than on 
the non-coated titanium (Figure 3 a and b). These results suggest an enhanced cell 
mineralisation when cultured on the coated implants [16,17]. 
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COL I expression was similar for the two materials throughout the experiment. After 7 
days of culture, the OCN expression levels were significantly higher for the non-coated 
titanium than for the coated surfaces (Figure 3 c and d). OCN is a pre-osteoblastic marker; 
its diminished expression levels on the 70M30T surfaces supports the hypothesis that the 
sol-gel material accelerates the osteogenesis processes [18]. 
 
 
Figure 3. Gene expression of osteogenic markers (a) ALP, (b) IL6, (c) COL I and (d) OCN in MC3T3-E1 
osteoblastic cells cultured on SAE-Ti (white bar) and 70M30T (grey bar). The relative mRNA expression was 
determined by RT-PCR after 7 and 14 days of culture. Statistical analysis was performed using one-way ANOVA 
with a Kruskal-Wallis post-test (* p ≤ 0.05). 
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iii. In vivo assays 
The results of in vivo experiments showed similar regeneration behaviours for the two implants 
tested. SAE-Ti implants displayed, as expected, good osteointegration after 2 and 4 weeks (Figure 
4). In some of the roots of the threads of the 70M30T-coated implants, an unstained material 
corresponding to the remaining sol-gel coating was observed. The 70M30T implants also showed 
good osteointegrative properties, and qualitatively, the osteogenic activity seemed higher than on 
the SAE-Ti surfaces. As shown in Figure 5, 70M30T-coated surface induced the growth of new bone 
tissue spicules from the cortical region into the medullary cavity. 
 
Figure 4. Microphotographs of samples of SAE-Ti and 70M30T implants. The main panels show 4× 
magnification images of regions close to the cortical bone (up) and the bone marrow cavity (down). In the 
inserts (lower-right corners), 10× images of the same regions are shown. 
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Figure 5. Bone tissue growth 4 weeks after implantation. Panoramic (left) and detailed (right) 
microphotographs of SAE-Ti and 70M30T implants show the bone tissue generated around the implant 
surface. 
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iv. Proteomic analysis 
The LC-MS/MS analysis identified 113 proteins. The statistical comparison of the results obtained 
for SAE-Ti and 70M30T materials was carried out using the Progenesis QI software. The DAVID and 
PANTHER programmes were employed to classify the detected proteins according to their 
function. 
The comparison between the proteins identified on the two tested materials revealed that only 1 
protein preferentially adsorbed onto the 70M30T surface (CLUS, classified as a glycoprotein by 
DAVID). However, 31 proteins favoured the SAE-Ti (Table I). Within this group, a large number of 
lipoproteins were found, such as apolipoproteins APOA2, APOA5, APOC1, APOC3, APOC4, APOE, 
APOL1 and the SAA4, a high-density lipoprotein particle. Several proteins associated with blood 
coagulation functions were also identified. The coagulation factors FA5, FA10 and FA11, THRB, 
ANT3, PLMN, PROC and PROS belong to this set of proteins. Moreover, DAVID listed HRG, PLMN, 
PROS, THRB and KLKB1 as proteins involved in fibrinolysis process. TETN, SEPP1, PF4V and VTNC 
were classified as glycoproteins. Intracellular proteins such as keratins K2C1B and K2C4 were also 
found. 
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Table I. Proteins differentially attached to 70M30T and Ti (Progenesis analysis). ANOVA (p-value < 0.05) (Table 
continues next page) 
    
Normalized abundance 
Description Accession 
Confidence 
score Anova (p) 
Average 
70M30T Average Ti 
Ratio 
Ti/70M30T 
Clusterin CLUS_HUMAN 596,70 3,95E-03 7,50E+05 4,89E+05 0,65 
Keratin, type II cytoskeletal 
1b K2C1B_HUMAN 292,46 7,61E-03 4,81E+03 6,41E+03 1,33 
Apolipoprotein C-III APOC3_HUMAN 212,82 4,42E-02 4,51E+05 7,69E+05 1,71 
Apolipoprotein L1 APOL1_HUMAN 235,45 8,28E-04 9,45E+04 1,64E+05 1,73 
Plasminogen PLMN_HUMAN 781,12 1,62E-02 2,36E+05 4,32E+05 1,83 
Ig lambda chain V-III region 
SH LV301_HUMAN 120,13 1,25E-02 3,67E+04 7,51E+04 2,05 
Coagulation factor V FA5_HUMAN 192,62 2,04E-05 9,83E+03 2,04E+04 2,08 
Apolipoprotein A-V APOA5_HUMAN 194,49 1,14E-03 8,91E+03 2,41E+04 2,70 
Vitamin K-dependent 
protein S PROS_HUMAN 78,23 9,83E-03 4,21E+03 1,20E+04 2,85 
Ig kappa chain V-III region 
SIE KV302_HUMAN 153,44 5,26E-03 8,45E+04 2,56E+05 3,03 
Plasma kallikrein KLKB1_HUMAN 86,19 1,60E-04 2,91E+03 9,45E+03 3,24 
Tetranectin TETN_HUMAN 206,13 3,01E-03 8,11E+03 2,72E+04 3,35 
Selenoprotein P SEPP1_HUMAN 208,07 2,92E-05 1,94E+04 6,99E+04 3,60 
Apolipoprotein A-II APOA2_HUMAN 144,49 1,00E-03 6,31E+04 2,77E+05 4,39 
Antithrombin-III ANT3_HUMAN 488,69 3,49E-04 6,55E+04 3,14E+05 4,80 
Apolipoprotein E APOE_HUMAN 1831,27 5,56E-07 1,82E+06 9,32E+06 5,11 
Prothrombin THRB_HUMAN 369,68 9,15E-04 4,62E+04 2,77E+05 5,99 
Keratin, type II cytoskeletal 4 K2C4_HUMAN 155,48 1,60E-02 8,74E+02 5,76E+03 6,59 
Serum amyloid A-4 protein SAA4_HUMAN 135,14 7,04E-04 4,94E+04 3,45E+05 6,98 
Kininogen-1 KNG1_HUMAN 350,85 6,48E-06 5,49E+04 4,16E+05 7,59 
Coagulation factor XI FA11_HUMAN 296,94 1,56E-05 1,78E+04 1,96E+05 11,00 
Platelet basic protein CXCL7_HUMAN 82,00 1,28E-06 2,48E+03 2,90E+04 11,70 
Apolipoprotein C-I APOC1_HUMAN 185,56 9,22E-08 2,51E+05 2,97E+06 11,81 
Apolipoprotein C-IV APOC4_HUMAN 96,41 3,11E-06 6,24E+03 7,86E+04 12,60 
Creatine kinase M-type KCRM_HUMAN 146,67 2,33E-05 9,78E+02 2,26E+04 23,08 
Histidine-rich glycoprotein HRG_HUMAN 527,94 4,86E-07 3,90E+04 9,09E+05 23,33 
Coagulation factor X FA10_HUMAN 81,54 5,51E-06 8,72E+02 2,31E+04 26,53 
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Description Accession 
Confidence 
score Anova (p) 
Average 
70M30T Average Ti 
Ratio 
Ti/70M30T 
Vitamin K-dependent 
protein C PROC_HUMAN 70,62 1,74E-03 1,90E+02 5,96E+03 31,28 
Vitronectin VTNC_HUMAN 307,15 3,10E-03 7,52E+04 2,99E+06 39,76 
Platelet factor 4 variant PF4V_HUMAN 117,94 2,64E-05 3,19E+02 2,68E+05 840,27 
 
The PANTHER pie chart in Figure 6 shows the functional classification of the proteins adhering 
more to the SAE-Ti than to 70M30T surface. The most common biological functions were related 
to cellular processes (19%), biological regulation (14%) and response to stimulus (14%). Notably, a 
proportion of associated functions were represented by the immune system processes (3%). 
Among the proteins linked to various pathway processes, 84% were associated with blood 
coagulation. Two small groups of proteins (8%) were linked to the plasminogen activating cascade 
and inflammation. 
 
 
Figure 6. PANTHER pie charts with the biological process (A) and pathway (B) functions for the proteins 
adhering predominantly to SAE-Ti in comparison with 70M30T surfaces. 
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d. DISCUSSION 
 In the recent years, improving the bioactivity of materials has become an utmost standard field of 
study for biomaterial studies, in particular in the field of dental science. The successful 
incorporation of an implant into a living organism involves a series of unknown biological 
mechanisms, including processes like coagulation and immune response, leading to a desired 
correct bone regeneration [19]. These processes are triggered by the first layer of proteins 
adsorbed on the biomaterial surfaces, conditioning and determining cell behaviour during the 
post-implantation recovery [14]. After a surgical procedure, there are some immediate 
interactions between those proteins and the biomaterial. The extent and type of these interactions 
largely depend, apart from the biochemistry of the organism, on the physical and chemical surface 
characteristics of the implant. These characteristics often determine a specific type, quantity and 
conformation of the proteins attaching to the implant surface via competitive displacement, 
known as the Vroman effect [20]. Hence, this experimental work focused on the interactions 
between the implant surface and serum proteins. 
The intrinsic physico-chemical characteristics of the tested surfaces can condition the cellular 
behaviour and, consequently, modulate the adaptation to the implanted foreign body. The analysis 
of the materials examined here showed clear differences between their chemical composition and 
physico-chemical properties (hydrophilicity, topography and contact angle). 
These differences were not unexpected given the characteristic, distinct cell behaviour in response 
to each surface type. The 70M30T coating triggered stronger cell responses, particularly noticeable 
on the mRNA expression levels. The expression of ALP and IL-6, the major biomarkers of osteogenic 
differentiation [16, 17], was enhanced in the cells exposed to the coated surface in comparison 
with the uncoated SAE-Ti surfaces. The difference was sufficiently significant to infer that this 
coating affected the cell behaviour. 
However, in the in vivo experiments, these differences were not so clear-cut (Figure 4). These 
results suggest that the processes underlying the osseointegration for these two surface types are 
distinct or regulated by different mechanisms (Figure 5). 
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In the case of SAE-Ti, the regeneration process might be based on osteoconduction, while the bone 
repair achieved using the 70M30T implants might be primarily based on osteoinduction. The 
differences between the compositions of the respective protein layers suggest a correlation 
between the attached proteins and the particular mechanism of bone regeneration. The 
examination of the proteins adsorbed onto different surfaces might help to find this correlation. 
Only one protein, CLUS, was adsorbed preferentially to the 70M30T-coated surface. This protein 
has been associated with several functions. Among those, there are some processes with a role in 
inflammation and immunity, such as the regulatory activity of complements [21]. In contrast, 31 
proteins were significantly and predominantly attached to the SAE-Ti surface. A substantial number 
of apolipoproteins were part of this group. Apolipoproteins, besides their function in lipid 
metabolism, might prevent the initiation of innate immunity [22]. Immunoglobulins LV301 and 
KV302 were two of the characteristic proteins attached to the titanium surface; this could be 
related to the immune system process functions (3%) shown in Figure 6. Although the proteomic 
study was carried out using human serum, some intracellular proteins such as keratins were 
obtained during the elution. The presence of these molecules could be an artefact of the industrial 
process used to purify the serum. According to DAVID classification, some of the proteins with 
more affinity to SAE-Ti than to 70M30T (HRG, PLMN, PROS, THRB and KLKB1) are involved in the 
fibrinolysis process. These proteins, as well as FA5, FA10, FA11, PROC, ANT3 and KNG1, are also 
related to the coagulation system. The PANTHER classification (pathway functions) indicates that 
84% of the proteins preferentially adhering to SAE-Ti are associated with the blood coagulation 
(Figure 6). Both fibrinolysis and coagulation are the processes necessary to achieve a correct bone 
tissue repair [23]. Among the SAE-Ti-associated proteins, FA5, FA10, FA11 and THBR might play a 
role in blood coagulation pathway, promoting blood clotting. ANT III, PROC and PROS are involved 
in the regulation of this pathway [24]. PLMN has an important role in the plasminogen system 
activation, the key step in the fibrinolysis process. After trauma, the coagulation system is one of 
the main initiators of the development of blood clots. Following this event, the plasminogen 
system acts during the extracellular matrix degradation and the consequent tissue remodelling and 
angiogenesis, leading to correct tissue healing [25]. The HRG protein is associated with blood 
coagulation, fibrinolysis and innate immune systems. It could function as both anticoagulant and 
antifibrinolytic modulator and might regulate platelet function in vivo [26]. KLKB1 is involved in the 
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regulation of multiple proteolytic cascades, such as the intrinsic pathway of coagulation, as well as 
the fibrinolytic system and the complement pathways [27]. In addition, KLKB1, in association with 
FA12 and high-molecular-weight KNG1, forms the kinin–kallikrein surface-activated coagulation 
system [28]. 
Some of the SAE-Ti-attached proteins, such as VTNC, TETN and APOE, might have osteogenic 
activity. APOE has a role in the vitamin K uptake into osteoblasts [29]. VTNC could promote the 
human osteoblast attachment and proliferation on the Ti implants, accelerating the 
osseointegration process [30]. The TETN protein has been linked to correct bone tissue 
development; TETN-knock-out mice have kyphosis and show the symptoms of osteoporosis [31]. 
On the basis of the available data and the in vitro and in vivo results obtained here, it is tempting 
to suggest a relationship between the type and function of these proteins and different 
mechanisms of osseointegration in vivo. The 70M30T material, releasing Si compounds into the 
implant surroundings might stimulate the undifferentiated osteoblasts, leading to the formation 
of bone tissue [32, 33]. This would represent a case of osteoinduction in the tissue surrounding the 
implant; such assumption is supported by the overexpression of osteogenesis-related genes, ALP 
and IL-6, demonstrated here. This mechanism could not be proven by the proteomic analysis of 
the eluate from the implant surface. 
However, the predominance of coagulation- and fibrinolysis-related proteins adsorbed onto the 
SAE-Ti surface could indicate an ongoing osteoconduction process with the participation of key 
proteins such as PLMN and VTNC. This result illustrates the validity of the proteomic analysis, 
reflecting the in vivo outcome. Moreover, the coagulation might be the result of the kallikrein-kinin 
system activation. This is consistent with the hypothesis that the coagulation and, consequently, 
the regeneration, spreading from the titanium surface to the medullar area of the implanted bone, 
are based on an osteoconductive process. 
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e. CONCLUSIONS 
 Two different dental implants, sandblasted acid-etched titanium (SAE-Ti) and a silica sol-gel hybrid 
coating (70M30T), were characterised. The results suggest two different mechanisms of bone 
regeneration. The SAE-Ti surfaces display osteoconductive properties. However, the in vivo results 
for silica sol-gel implants suggest osteoinductive behaviour. These results were confirmed by in 
vitro testing. The 70M30T coating displayed strong cell activation properties. The mRNA expression 
levels for ALP and IL-6, important biomarkers of osteogenic differentiation, were higher for 
70M30T than for SAE-Ti surfaces. The results of proteomic analysis could explain some differences 
observed in bone healing. In particular, the effect of surface properties on cell behaviour could 
shed some light on the osteoconduction phenomenon. It is tempting to infer that certain proteins 
related to coagulation processes take part in the initial regenerative events on the biomaterial 
surface. 
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ABSTRACT  
Osseointegration, including the foreign body reaction to biomaterials, is an immune-modulated, 
multifactorial, and complex healing process in which various cells and mediators are involved. The 
buildup of the osseointegration process is immunological and inflammation-driven, often triggered 
by the adsorption of proteins on the surfaces of the biomaterials and complement activation. 
New strategies for improving osseointegration use coatings as vehicles for osteogenic 
biomolecules delivery from implants. Natural polymers, such as gelatin, can mimic collagen I and 
enhance the biocompatibility of a material. In this experimental study, two different base sol-gel 
formulations and their combination with gelatin, were applied as coatings on sandblasted, acid-
etched titanium (SAE-Ti) substrates and their biological potential as osteogenic biomaterials was 
tested. We examined the proteins adsorbed onto each surface and their in vitro and in vivo effects. 
In vitro results showed an improvement in cell proliferation and mineralization in gelatin-
containing samples. In vivo testing showed the presence of a looser connective tissue layer in those 
coatings with substantially more complement activation proteins adsorbed, especially those 
containing gelatin. Vitronectin and FETUA, proteins associated with mineralization process, were 
significantly more adsorbed in gelatin coatings.   
 
 
Keywords:  
Dental implants; biocompatibility; biomaterial, immunology; complement pathway; bone 
regenerati 
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a. INTRODUCTION 
 The regenerative processes in the bone entail responses to continuous biological challenges. The 
sequence of bone induction and conduction events, involving various types of cells and signaling 
pathways in a determined order, is necessary to achieve an ideal regeneration [1]. The implants 
used in the field of bone regeneration have been continuously studied and optimized since the last 
century. The results of implantation depend largely on the deposition of signaling proteins onto 
the surface of a biomaterial and will define the magnitude and type of the reaction (specially 
inflammatory, immune, and coagulation) of the host to the foreign body implantation [2].   
The complement cascade is involved in a variety of physiological and pathophysiological processes, 
apart from its role as an immune effector. This cascade also regulates the cellular turnover, healing, 
proliferation, and regeneration [3]. The disproportionate long-term effects are generally 
interpreted as implant rejection events. These responses involve mostly uncontrolled blood 
coagulation processes, the development of infection, and the formation of immune structures (e.g. 
fibrous capsule) surrounding the foreign body and infected or damaged tissue.  
Biomaterials are manufactured and tested to improve the life quality of the patient by minimizing 
the impact of the implanted foreign body and achieving the recovery in the shortest time possible 
[4,5]. Assessing the viability of biomaterials involves a battery of extensive tests before the final 
product can be released to the market; these tests normally entail both in vitro and in vivo 
procedures. In vivo testing is the ideal standard in new biomaterial trials as it examines their effects 
on a living organism. However, in vitro testing is the first and necessary step to exclude the 
immediate damage to the organism; it can also help to avoid the ethical problems and minimize 
the costs. However, the in vivo results often do not reflect the in vitro outcomes. This problem is 
invariably emphasized by the experts in the field of regenerative bone engineering. Thus, new 
approaches and tools are needed to avoid detrimental side effect and predict the efficacy of 
biomaterials [6].  
Silica sol-gel hybrid materials are often used in biomedical applications due to the relative ease of 
controlling their degradation kinetics and the network pore size. These materials degrade by 
releasing silicon compounds in the Si(OH)4 form to the surrounding microenvironment, providing 
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a good osteogenic setting for the new bone tissue formation [7–9]. Moreover, the process itself 
results in a good grade of purity at low temperatures. Gelatin is occasionally embedded in the 
surface of the biomaterial to favour biocompatibility, cell adhesion, proliferation and 
differentiation [10,11] because it can mimic the chemical and biological functions of collagen I in a 
living organism [12].  
In the silicon networks, gelatin can be effectively crosslinked with an inorganic sol-gel alkoxysilane 
matrix without losing its osteogenic properties [13]. This is useful for controlling the degradation 
rate, and gelatin can be used as a therapeutic agent in the matrix under mild conditions [14,15]. 
Different gelatin-silica composites have been developed and studied, and good biocompatibility of 
these systems has been demonstrated [16–19]. Lei et al. have set silica-gelatin hybrid implants 
using 3-glycidoxypropyl-trimethoxysilane (GPTMS) and tetraethoxysilane (TEOS) alkoxysilanes as 
precursors. Biological assays have shown that these materials have good biocompatibility and they 
enhance cell proliferation [16,17]. 
In a previous work sol-gel compositions with gelatine physically or chemically entrapped were 
sinthetized, achieving different physico-chemical properties [20]. The protein adsorption onto 
these gelatin-silica networks was studied with quartz crystal microbalance using monoprotein 
solutions and distinct affinities were detected when the gelatin was present [21].  
In this experimental study, two sol-gel coating bases and their silicon-gelatin correspondents were 
applied as coatings on sandblasted, acid-etched titanium disc substrates/implants (SAE-Ti), and 
their biological potential as biomaterials was tested. The compositions with gelatin and their 
respective base materials were incubated with human serum, simulating a more real setup. Their 
effects on the adsorbed protein layer using mass spectrometry (LC-MS/MS) were examined, and 
the in vitro and in vivo outcomes were studied. 
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b. MATERIALS AND METHODS 
i. Titanium discs 
 Ti discs (12 mm in diameter, 1-mm thick) were made from a bar of commercially available, pure, 
grade-4 Ti (Ilerimplant S.L., Lleida, Spain). To obtain the sandblasted, acid-etched (SAE) Ti, the discs 
were abraded with 4-μm aluminum oxide particles and acid-etched by submersion in sulfuric acid 
for 1 h to simulate a moderately rough implant surface. Discs were then washed in acetone, 
ethanol, and 18.2-Ω puriﬁed water (for 20 min in each liquid) in an ultrasonic bath and dried under 
vacuum. Finally, all Ti discs were sterilized using UV radiation. 
 
ii. Sol-gel synthesis and sample preparation 
The silica-gelatin hybrid coatings were obtained through the sol-gel route. The precursor 
alkoxysilanes used were methyltrimethoxysilane (MTMOS), 3-(glycidoxypropyl)-trimethoxysilane 
(GPTMS) and tetraethyl orthosilicate (TEOS) (Sigma-Aldrich, St. Louis, MO, USA). Four different 
compositions were synthesized. We obtained two silica materials with molar percentages of 70% 
MTMOS and 30% TEOS (70M30T) and 35% MTMOS, 35% GPTMS, and 30% TEOS (35M35G30T). 
Their respective composites (70M30T-GEL and 35M35G30T-GEL) were made with 0.9% (weight 
relative to the amount of alkoxysilane) of gelatin from porcine skin (Sigma-Aldrich, St. Louis, MO, 
USA). The two gelatin-free compositions were synthesized using 2-Propanol (Sigma-Aldrich, St. 
Louis, MO, USA) as solvent at a volume ratio (alcohol: siloxane) of 1:1. Hydrolysis of alkoxysilanes 
was carried out by adding (at a rate of 1 drop s-1) the corresponding stoichiometric amount of 0.1M 
HNO3 acid aqueous solution (Panreac, Barcelona, Spain). The solution was kept for 1 h under 
stirring and then 1 h at rest. The materials with gelatin were prepared using a mixture of 50% 2-
Propanol and 50% distilled water as a solvent at a volume ratio (solvent: siloxane) of 1:1. After 
adding the alkoxysilane precursors, the hydrolysis was carried out by adding (at 1 drop s-1) the 
stoichiometric amount of 0.1M HCl acidified aqueous solution (Panreac, Barcelona, Spain) with the 
dissolved gelatin. The solution was kept 1 h under stirring and then 1 h at rest, at 37 ºC. The samples 
were prepared immediately afterward. SAE-titanium was used as a substrate. The coating was 
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performed employing a dip coater (KSV instrument-KSV DC). Discs and implants were immersed in 
the corresponding sol-gel solution at a speed of 60 cm min-1, left immersed for one minute, and 
removed at a 100 cm min-1. Finally, the samples were cured for 2 h at 80 ºC. 
 
iii. Physico-chemical characterisation of the coated 
titanium discs 
 A mechanical profilometer Dektak 6M (Veeco, NY, USA) was used to determine the roughness. 
Two coated discs of each composition were tested. Three measurements were performed for each 
disc to obtain the average values of the Ra parameter. The contact angle was measured using an 
automatic contact angle meter OCA 20 (Dataphysics Instruments, Filderstadt, Germany). Ten µL of 
ultrapure water W04 were deposited on the sol-gel coated surface at a dosing rate of 27.5 μL s-1 at 
room temperature. Contact angles were determined using SCA 20 software. Five discs of each 
material were studied, after depositing two drops on each disc. The surface topography of the 
coatings was characterized using scanning electron microscopy (SEM) employing the Leica-Zeiss 
LEO equipment under vacuum (Leica, Wetzlar, Germany). Platinum sputtering was applied to make 
the samples more conductive for the SEM observations. 
 
 
iv. In vitro assays 
 MC3T3-E1 (mouse calvaria osteosarcoma cell line) cells were cultured on the sol-gel coated 
titanium discs at a concentration of 1 × 104 cells/well, in Dulbecco’s modified Eagle’s medium 
(DMEM) with phenol red (Gibco-Life Technologies, Grand Island, NY, USA), 1 % 100× 
penicillin/streptomycin (Biowest Inc., Riverside, KS, USA), and 10 % fetal bovine serum (FBS) 
(Gibco-Life Technologies, Grand Island, NY, USA). After incubation for 24 hours at 37 ºC in a 
humidified (95 %) atmosphere of 5 % CO2, the medium was replaced with an osteogenic medium 
composed of DMEM with phenol red 1×, 1 % penicillin/streptomycin, 10 % FBS, 1 % ascorbic acid 
(5 mg mL-1), and 0.21 % β-glycerol phosphate, and incubated again under the same conditions. The 
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culture medium was changed every 48 hours. In each plate, a well with cells at the same 
concentration (1 × 104 cells) was used as a control of culture conditions. 
The biomaterial cytotoxicity was assessed following the ISO 10993-5 norm, measured by 
spectrophotometry, by contact of the material extract with the cell line. The 96-Cell Titter 
Proliferation Assay (Promega®, Madison, WI, USA) was employed to measure the cell viability after 
24-h incubation of the cells with the extract. We used one negative control (empty cell well) and a 
positive control with latex, known to be toxic to the cells. Seventy-percent cell viability was the 
limit below which a biomaterial was considered cytotoxic. 
For measuring cell proliferation, the commercial cell viability assay alamar Blue® (Invitrogen-
Thermo Fisher Scientific, Waltham, MA, USA) was used. This kit measures the cell viability on the 
basis of a redox reaction with resazurin. The cells were cultured in wells with the discs (3 replicates 
per treatment) and examined following the manufacturer’s protocol after 4 days, 8 days, and 14 
days. The percentage of reduced resazurin was used to evaluate cell proliferation. 
To obtain the samples for total protein measurement (BCA) and ALP activity, the culture medium 
was removed from the wells, the wells were washed three times with 1 × DPBS, and 100 μL of lysis 
buffer (0. 2 % Triton X-100, 10 mM Tris-HCl, pH 7.2) were added to each well, obtaining the cell 
lysate. After being kept on ice for 10 min, the lysate was sonicated and centrifuged for 7 min at 
13,300 rpm and the supernatant was used to measure the total protein content and the ALP 
activity. Each sample was pipetted in triplicate (5 µL per well).  
The total protein content was calculated from a standard curve for bovine albumin and expressed 
as μg μL−1, following the manufacturer’s instructions, using the colorimetric measurement of BCA 
at 570 nm on a microplate reader Multiskan FC® (Thermo Scientific®). 
The conversion of p-nitrophenylphosphate (p-NPP) to p-nitrophenol was used to assess the 
alkaline phosphatase (ALP) activity. Sample Aliquots of 0.1 mL were used to carry out the assay. 
One hundred µL of p-NPP (1 mg mL-1) in substrate buffer (50 mM glycine, 1mM MgCl2, pH 10.5) 
was added to the 100 µL of the supernatant obtained from the lysate. After two hours of incubation 
in the dark (37 ºC, 5 % CO2), absorbance was measured using a microplate reader at a wavelength 
of 405 nm. ALP activity was obtained from a standard curve obtained using different solutions of 
p-nitrophenol and 0.02 mM sodium hydroxide. Results were presented as mmol of p-
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nitrophenol/hour (mmol PNP h-1), and data were expressed as ALP activity normalized by the total 
protein content (µg µL-1) obtained using Pierce BCA assay kit (Thermo Fisher Scientific, Waltham, 
MA, USA) after 7 and 14 days. 
 
 
ii. Statistical analysis 
Data were submitted to one-way analysis of variance (ANOVA) and to a Newman-Keuls multiple 
comparison post-test, when appropriate. Differences with p ≤ 0.05 were considered statistically 
significant. 
 
iii. In vivo experimentation 
 To assess the in vivo behaviour to the selected coatings, coated dental implants were surgically 
placed in the tibia of New Zealand rabbits (Oryctolagus cuniculus). This implantation model is 
widely used to study the osseointegration of dental implants [22]. All the experiments were 
conducted in accordance with the protocols of Ethical Committee of the Valencia Polytechnique 
University (Spain), the European guidelines and legal conditions laid in R. D. 223/1988 of March 
14th, and the Order of October 13rd, 1988 of the Spanish Government on the protection of animals 
used for experimentation and other scientific purposes. The rabbits were kept under 12-h span 
darkness-light cycle; room temperature was set at 20.5 ± 0.5 °C, and the relative humidity ranged 
between 45 and 65 %. The animals were individually caged and fed a standard diet and filtered 
water ad libitum. Dental implants were supplied by Ilerimplant S.L. (Lleida, Spain). They were the 
internal-connection dental implants, made with titanium grade 4, (trademark GMI), of 3.75-mm 
diameter and 8-mm length. We used the Frontier model, with SAE surface treatment. Overall, 40 
implants were used, 20 uncoated (control) and 5 coated (test samples) with each material. The 
control and test samples were implanted under the same conditions.  
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We used 20 rabbits, 5 for each material, with weights between 2000 and 3000 g, of the age near 
the physical closure (indicative of an adequate bone volume). The implantation period for the 
experimental model was 2 weeks. Implants were inserted in both left and right proximal tibiae, 
each animal receiving two implants (one control sample and one test sample). Animals were 
sedated (chlorpromazine hydrochloride) and prepared for surgery, and then anesthetized 
(ketamine hydrochloride). A coetaneous incision was made in the implantation site in the proximal 
tibia. The periosteum was removed, and the osteotomy was performed using a low revolution 
micromotor and drills of successive diameters of 2, 2.8, and 3.2 mm, with continuous irrigation. 
Implants were placed by press-fit, and surgical wound was sutured by tissue planes, washed with 
saline and covered with plastic spray dressing (Nobecutan, Inibsa Laboratories, Barcelona, Spain). 
After each implantation period, the animal was euthanized by carbon monoxide inhalation, and 
the implant screws were retrieved to study the surrounding tissues. 
Samples for histological examination were processed following the method described by Peris et 
al. [23]. Briefly, the samples were embedded in methyl methacrylate, and 25–30 µm thick sections 
were obtained using EXAKTtechnique (EXAKT Technologies, Inc., Oklahoma, USA). For optical 
microscopy examination, all the sections were stained using Gomori Trichrome solution. 
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iv. Adsorbed protein layer 
 Sol-gel coated titanium discs were incubated in a 24-well plate for 180 min in a humidified 
atmosphere (37 ºC, 5 % CO2), after the addition of 2 mL of human blood serum from male AB 
plasma (Sigma-Aldrich, St. Louis, MO, USA). 
The serum was removed, and, to eliminate the non-adsorbed proteins, the discs were rinsed five 
times with ddH2O and once with 100 mM NaCl, 50 mM Tris-HCl, pH 7.0. The adsorbed protein layer 
was collected by washing the discs in 0.5 M Triethylammonium bicarbonate buffer (TEAB) with 4 
% of sodium dodecyl sulfate (SDS) and 100 mM of Dithiothreitol (DTT). The experimental method 
was adopted from a study by Kaneko et al. [24]. Four replicates for each biomaterial were obtained. 
The total protein content of the serum employed to this study was quantified before the 
experiment (Pierce BCA assay kit; Thermo Fisher Scientific, Waltham, MA, USA), obtaining a value 
of 51 mg mL-1. 
 
 
v. Protein analysis 
Proteomic analysis was performed as described by Romero-Gavilán et al. [25], with minor 
variations. Briefly, the same amount of sample (2/10 of the eluted material) was loaded in each 
lane for the same experimental conditions. The eluted protein was resolved in polyacrylamide gels; 
the gels were cut into slices. Each of these slices was digested with trypsin and loaded onto a 
nanoACQUITY UPLC system connected online to a SYNAPT G2-Si MS System (Waters, Milford, MA, 
USA). Differential protein analysis was carried out using Progenesis software (Nonlinear Dynamics, 
Newcastle, UK) as described before [25], and the functional annotation of the proteins was 
performed using PANTHER (www.pantherdb.org/) and DAVID Go annotation programs 
(https://david.ncifcrf.gov/). Uniprot (http://www.uniprot.org/) nomenclature was adopted to 
name the proteins without the ending “_HUMAN”. 
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c. RESULTS 
 i. Synthesis and physicochemical characterisation 
Our chosen synthesis parameters allowed us to obtain different materials, all with homogenous 
surfaces, as can be seen in the SEM micrographs (Figure 1). The 70M30T coating had different 
morphology in comparison with 35M35G30T. However, no differences in morphology were 
detected when gelatin was incorporated in the networks. This agrees with the data obtained using 
the mechanical profilometer. 70M30T and 70M30T-GEL materials had an average surface 
roughness (Ra) of 0.77 ± 0.13 and 0.79 ± 0.07 µm, respectively. The compositions 35M35G30T and 
35M35G30T-GEL exhibited lower roughness (Ra of 0.51 ± 0.14 µm and 0.58 ± 0.15 µm, 
respectively).
 
Figure 1. Scanning electron microscopy images of hybrid sol–gel coatings onto titanium discs: 70M30T (a), 
70M30T‐GEL (b), 35M35G30T (c), and 35M35G30T‐GEL (d). Calibration bar 10 μm. 
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The contact angle measurements (Figure 2) gave similar values for 70M30T and 35M35G30T 
coatings. However, the addition of gelatin caused a decrease in wettability on both materials. 
 
 
 
 
 
 
 
Figure 2.  Contact angle measurements of 70M30T, 70M30T‐GEL, 35M35G30T, and 35M35G30T‐GEL sol–gel 
coatings. ANOVA (p-value < 0.05). 
 
ii. In vitro assays 
None of the biomaterials tested was cytotoxic. After 7 days of incubation, we found no differences 
between the ALP activities for the examined materials or even between these materials and SAE-
Ti. Interestingly, after 14 days, we observed a significant increase in the ALP activity on the material 
35M35G30T-GEL in comparison with the other formulations even though this material had the 
lowest activity after 7 days (Figure 3). After 14 days, cell proliferation increased slightly on the 
formulations with gelatin in comparison with their base materials; the cultures grown on the 
formulation 70M30T-GEL showed higher levels of proliferation than the control cells. We noted 
that the proliferative potential of 70M30T base material was better than the proliferative 
properties of 35M35G30T. 
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Figure 3. MC3T3‐E1 in vitro results. (a) Alkaline phosphatase activity (mM p‐nitrophenol [PNP]/hr) normalized 
to the amount of total protein (μg/μl) levels and (b) proliferation results of the cells cultivated on titanium 
discs treated with 70M30T, 70M30T‐GEL, 35M35G30T, 35M35G30T‐GEL formulations. Cells on an empty well 
without disc were used as a positive control (black column), whereas uncoated titanium discs (white column) 
were used as a negative control. ANOVA (p-value < 0.05). 
iii. In vivo assays 
Titanium implant coatings generated a distinctive tissue response at the experimental time tested. 
In the screw grooves corresponding to the cortical region no new bone tissue was observed in 
70M30T and 35M35G30T coated implants. When implants were coated with a mixture of gelatin 
combined with either of the two sol-gel solutions new bone tissue growing was observed filling the 
grooves. From the cortical bone new bone trabeculae grew towards the implant surface region 
located in the medullary cavity. The relative length of the trabeculae as well as their density was 
slightly higher for the 70M30T implants when compared to the other 3 experimental groups (Figure 
4). Furthermore, in the medullary cavity a fibrous connective tissue was developed also around the 
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implant surface of the 70M30T samples, containing arterial vessels. The connective tissue was 
looser and the arterial vessels density lower around 35M35G30T coated implants and those 
implants coated with a formulation containing gelatin. The inflammatory response was lower for 
the 70M30T coating considering the relative density and size of giant multinucleated cells laying 
the implant coating.  
 
Figure 4. Microphotographs of titanium implants. Panoramic images of (a) 70M30T, (b) 70M30T‐GEL, (c) 
35M35G30T, and (d) 35M35G30TGEL implants. The delineated regions (blue rectangles) in the medullary 
cavity of (a) and (d) images are shown magnified in Figure 5. 
 
Thus, few osteoclast-like and multinucleated giant cells, most of them of a small size were observed 
in the grooves of the implant (Figure 5a). The relative density of giant cells was slightly higher for 
the 35M35G30T-coated implants. The addition of gelatin to the sol-gel coating was related to an 
evident increase of the giant cells size and cell density, that was about 3- and 4-times higher for 
the 70M30T- and 35M35G30T-GEL (Figure 5b) coatings, respectively. 
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Figure 5. Microscopic detail of areas corresponding to the medullary cavity. Multinucleated cells layering the 
groove surface of (a) 70M30T and (b) 35M35G30T‐GEL implants. The areas shown correspond to those 
delineated in Figure 4. Scale bar, 0.05 mm. 
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iv. Proteomic analysis 
The proteins eluted from each biomaterial were studied using LC-MS/MS. The Progenesis QI 
software was employed to compare the characteristic proteins adhering to the different surfaces. 
One hundred seventy-one proteins were detected and quantified for each surface coating. 
The comparison of identified proteins on the 70M30T and 35M35G30T materials displays 6 
proteins more absorbed onto the 35M35G30T coating (Table I), while CLUS, FA12 and APOA5 
proteins are more abundant on the 70M30T coating.  
 
Table I. The comparison of proteins differentially adhered to 70M30T and 35M35G30T sol-gel coatings 
(Progenesis analysis). ANOVA (p-value < 0.05). 
Description Accession 70M30T 35M35G30T 
35M35G30T/ 
70M30T 
Myosin-1 MYH1_HUMAN 5,71E+02 9,81E+03 17,19 
L-lactate dehydrogenase B chain LDHB_HUMAN 1,00E+04 1,22E+05 12,18 
Glutamate dehydrogenase 1, 
mitochondrial 
DHE3_HUMAN 8,24E+02 7,13E+03 8,65 
Ficolin-2 FCN2_HUMAN 7,05E+03 5,84E+04 8,28 
Complement C1q 
subcomponent subunit A 
C1QA_HUMAN 3,17E+04 9,68E+04 3,06 
Hemoglobin subunit alpha HBA_HUMAN 3,75E+04 6,50E+04 1,73 
Clusterin CLUS_HUMAN 6,81E+05 4,15E+05 0,61 
Coagulation factor XII FA12_HUMAN 1,34E+05 7,80E+04 0,58 
Apolipoprotein A-V APOA5_HUMAN 5,41E+03 2,85E+03 0,53 
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The comparison of the data obtained for the 70M30T and 70M30T-GEL materials reveals 5 proteins 
with increased adsorption to the composition with gelatin (C1QA, FINC, FETUA, LDHB, and CO8B), 
while only one (K2C71) is more abundant on the 70M30T coating (Table II).  
 
Table II. The comparison of proteins differentially adhered to 70M30T and 70M30T-GEL hybrid coatings 
(Progenesis analysis). ANOVA (p-value < 0.05). 
Description Accession 70M30T 70M30T-GEL 
70M30T-
GEL/70M30T 
Complement C1q subcomponent 
subunit A 
C1QA_HUMAN 3.17E+04 6.71E+04 2.12 
Fibronectin FINC_HUMAN 8.26E+03 1.54E+04 1.86 
Alpha-2-HS-glycoprotein FETUA_HUMAN 2.25E+05 3.91E+05 1.74 
L-lactate dehydrogenase B chain LDHB_HUMAN 1.00E+04 1.74E+04 1.73 
Complement component C8 beta 
chain 
CO8B_HUMAN 1.04E+04 1.50E+04 1.45 
Keratin, type II cytoskeletal 71 K2C71_HUMAN 8.38E+03 5.90E+03 0.70 
 
The PANTHER diagram showing classification by function is displayed in Figure 6. Although the 
70M30T material yielded only one differentially adhering protein (keratin), adding gelatin to the 
matrix induced the adhesion of proteins related with the immune system (14%) and the biological 
adhesion (14%).  
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Figure 6. PANTHER diagram with the biological process of the proteins differentially adhered to 70M30T‐GEL, 
respect 70M30T. 
Similarly, Table III shows the comparison between the compositions 35M35G30T and 35M35G30T-
GEL. In this case, 9 proteins were identified as more abundant on the composition with gelatin; 
CFAD, CO6, CRP, CO8B, and APOM were among them. However, the levels of adhering IGJ, CATD, 
HORN, and FCN2 were significantly higher for the 35M35G30T biomaterial. The GO functional 
classification of the proteins was performed using PANTHER system.  
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Table III. The comparison of proteins adhered to 35M35G30T and 35M35G30T-GEL hybrid coatings 
(Progenesis analysis). ANOVA (p-value < 0.05). 
Description Accession 35M35G30T 
35M35G30T-
GEL 
35M35G30T-GEL 
/35M35G30T 
Ig kappa chain V-I region 
Roy 
KV116_HUMAN 2.73E+04 7.34E+04 2.69 
Complement factor D CFAD_HUMAN 2.14E+04 4.98E+04 2.33 
Complement component 
C6 
CO6_HUMAN 2.15E+04 4.91E+04 2.28 
C-reactive protein CRP_HUMAN 6.62E+03 1.35E+04 2.04 
Complement component 
C8 beta chain 
CO8B_HUMAN 1.05E+04 2.13E+04 2.02 
Ig gamma-3 chain C region IGHG3_HUMAN 8.18E+04 1.47E+05 1.80 
Ig kappa chain V-II region 
Cum 
KV201_HUMAN 5.71E+05 9.69E+05 1.70 
Apolipoprotein M APOM_HUMAN 2.84E+04 4.74E+04 1.67 
Ig kappa chain V-IV region 
Len 
KV402_HUMAN 3.46E+05 5.28E+05 1.53 
Immunoglobulin J chain IGJ_HUMAN 9.79E+04 6.99E+04 0.71 
Cathepsin D CATD_HUMAN 3.65E+04 1.66E+04 0.46 
Hornerin HORN_HUMAN 8.79E+03 2.25E+03 0.26 
Ficolin-2 FCN2_HUMAN 5.84E+04 8.79E+03 0.15 
 
Figure 7a and 7b show the biological functions of the proteins differentially adsorbed onto 
35M35G30T and 35M35G30T-GEL, respectively. It is noteworthy that while the 35M35G30T 
proteins were only involved in 4 functions, after adding gelatin, we found differentially adhering 
proteins participating in 9 biological processes. Moreover, for the formulations with gelatin, the 
proportion of functions associated with immune system processes increased from 14 % to 20 %.  
 
 158 
 
 
Figure 7. PANTHER diagram with the biological processes of the proteins differentially adhered to 35M35G30T 
(a) and 35M35G30T‐GEL (b). 
The comparison between Table 2 and 3, give us the unique common differentially adhering protein 
common to the two materials with gelatin, a complement protein C08B. The comparison between 
the gelatin compositions is presented in Table IV. Sixteen proteins were preferentially adsorbed 
onto the 35M35G30T-GEL coating (e.g. S10A9, CFAD, CRP, SAMP, C1QC, and VTNC), while only 4 
were more abundant on the 70M30T-GEL (APOA, CLUS, APOA5, and IGJ). 
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Table IV. The comparison of proteins differentially adhered to 35M35G30T-GEL and 70M30T-GEL (Progenesis 
analysis). ANOVA (p-value < 0.05). 
Description Accession 70M30T-GEL 35M35G30T-GEL 
35M35G30T-
GEL/70M30T-GEL 
Glutamate dehydrogenase 1, 
mitochondrial 
DHE3_HUMAN 1.35E+03 1.67E+04 12.39 
L-lactate dehydrogenase B chain LDHB_HUMAN 1.74E+04 1.57E+05 9.01 
Myosin-1 MYH1_HUMAN 2.18E+03 6.79E+03 3.11 
Protein S100-A9 S10A9_HUMAN 3.74E+04 9.33E+04 2.49 
Complement factor D CFAD_HUMAN 2.13E+04 4.98E+04 2.34 
C-reactive protein CRP_HUMAN 6.08E+03 1.35E+04 2.22 
Serum amyloid P-component SAMP_HUMAN 2.54E+05 5.29E+05 2.09 
Ig kappa chain V-I region Roy KV116_HUMAN 3.79E+04 7.34E+04 1.93 
Ig kappa chain V-III region SIE KV302_HUMAN 2.44E+06 4.71E+06 1.93 
Complement C1q subcomponent 
subunit C 
C1QC_HUMAN 1.09E+06 1.90E+06 1.75 
Ig kappa chain V-II region Cum KV201_HUMAN 5.93E+05 9.69E+05 1.63 
Vitronectin VTNC_HUMAN 3.45E+05 5.50E+05 1.60 
Gelsolin GELS_HUMAN 1.58E+06 2.39E+06 1.51 
Complement C1s subcomponent C1S_HUMAN 2.43E+05 3.51E+05 1.45 
Ig gamma-3 chain C region IGHG3_HUMAN 1.03E+05 1.47E+05 1.43 
Actin, cytoplasmic 1 ACTB_HUMAN 4.88E+04 6.78E+04 1.39 
Immunoglobulin J chain IGJ_HUMAN 9.78E+04 6.99E+04 0.71 
Apolipoprotein(a) APOA_HUMAN 3.07E+04 1.78E+04 0.58 
Clusterin CLUS_HUMAN 9.81E+05 5.11E+05 0.52 
Apolipoprotein A-V APOA5_HUMAN 7.21E+03 3.71E+03 0.51 
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d. DISCUSSION 
The implantation of bone biomaterials triggers an immediate host response, provided by the 
immune system. Multi-directional pathways and mechanisms are activated, ultimately 
determining the integration or rejection of the biomaterial. These responses involve interactions 
between three types of components: the host immune cells, the host bone cells, and the materials 
themselves [26]. The initial layer of proteins adsorbed onto the biomaterial surface will ultimately 
define its biocompatibility, triggering, among other processes, coagulation, immune and 
angiogenesis signaling cascades. Hence, each biomaterial, depending on its chemical and physical 
composition, conformation, and intrinsic characteristics, can adsorb distinct sets and quantities of 
proteins to its surface. Titanium has been widely used as the base material for implants because 
of its bioinertia and osteoconductive characteristics [27]. Nowadays, various coatings are 
deposited onto this material to confer bioactive properties that enhance and accelerate the 
osseointegration in a living organism [28]. Our experimental work focused on the characterisation 
of the protein layer adsorbed onto four distinct biomaterials coated on the titanium discs (in vitro 
assays) or implants (in vivo experiments): 70M30T, 70M30T-GEL, 35M35G30T, and 35M35G30T-
GEL, and their correlation with in vitro and in vivo experimentation results. These silica sol-gel 
hybrid materials were selected because they confer bioactive properties to the titanium surface 
[8,29]. 
Gelatin-containing formulations were used to examine potential improvements in the 
biocompatibility as it might enhance the adhesion of the cells by mimicking the behaviour of 
collagen I. Some studies have combined gelatin with other materials with positive bone 
regeneration properties, such as calcium phosphates or silicon [16–18,30] improving the in vitro 
results [31]. 
Gelatin was incorporated in both sol-gel base compositions (70M30T and 35M35G30T). In 70M30T, 
the gelatin is kept in the silica network due to hydrogen bonds between amino and carboxyl groups 
from gelatin and silanol groups [32]. However, in 35M35G30T, it is anchored to the structure 
through covalent bonds formed by the reaction with the epoxy ring of the GPTMS precursor [18].  
The main chemical difference between the tested base materials (70M30T and 35M35G30T) is the 
presence of the GPTMS organic groups in the 35M35G30T. In general, physico-chemical results 
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display a decrease on roughness when GPTMS is added, whereas the incorporation of gelatin in 
both base materials shows an increase on hydrophobicity, possibly due to the special distribution 
of hydrophobic groups at the surface. Regardless of these differences, the in vitro results show 
non-significant or non-existent divergences between both base materials. The only exceptions 
were the increased cell proliferation on the 70M30T-GEL samples (result that it is described in the 
bibliography [16,17], and the significant increase in the ALP activity on 35M35G30T-GEL (Figure 3). 
However, it is worth mentioning the in vitro strategy adopted (using a single immortalized cell line), 
is not the ideal to simulate the whole in vivo setup of an implantation procedure, in which various 
biological systems and cues are involved, but it is the generally accepted standard for testing 
biomaterials nowadays. This in vitro setup gives the experimentation some clues about the 
material influence directly on the osteoblastic cell behaviour but does not consider parameters like 
the immune response and coagulative systems, which is something to take into account as a future 
perspective [33].  
Regarding proteomic analysis, it is interesting to observe the correlation between the base material 
35M35G30T and 70M30T (Table I), in vivo outcomes and the adsorbed layer of proteins formed 
onto each surface.  In particular, 35M35G30T-coating shows the formation of a thin fibrous 
connective tissue surrounding the material. In the mentioned comparative Table I, it is clear the 
greater adsorption of mainly two proteins directly related with the complement pathway: involved 
in the classical pathway (C1QA) and the lectin pathway (FCN-2), respectively [34]. 
Interestingly, between 70M30T and 70M30T-GEL (Table II), is notable a slightly greater adsorption 
of C1QA when the base material is supplemented with gelatin, which can explain the existence of 
a very thin sheet of fibrous connective tissue (Figure 4c). At the same time, it is clear the greater 
adsorption of FINC on the material with gelatin, which is a protein widely described to be involved 
on cellular adhesion and proliferative processes [35,36]. Notably, the proteins FETUA, CO8B, and 
C1QC were more abundant on the 70M30T-GEL than on its base material. C1QC and CO8B are pro-
inflammatory proteins. However, it is interesting to note that FETUA has been described as a 
modulator of macrophage opsonization, displaying anti-inflammatory activity, among its other 
functions. Moreover, this protein has a role in the fibril mineralization and may promote bone 
tissue formation [37]. 
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The comparison and characterisation of the layers of proteins formed on 35M35G30T and 
35M35G30T-GEL coated surfaces (Table III) showed more proteins related to the immune system 
adsorbed onto the 35M35G30T-GEL material (Figure 7), in particular, the proteins CO6, CFAD, 
CO8B, and CRP, a complement system activator [38]. Hence, in this aspect and at this point it is 
important to confirm the correlation between the greater adsorption of complement proteins and 
what is observed in regard to the increased presence of multinucleated giant cells around the 
gelatin-doped materials (Figure 5), that means that the incorporation of gelatin molecule supposes 
an increase in the immune response associated to the biomaterial.  
It was also observed the increased levels of adsorption (approximately 2-fold) of pro-inflammatory 
proteins onto the 35M35G30T-GEL in comparison with 70M30T-GEL, namely S10A9 [39], CFAD 
[40], CRP, SAMP, C1S, and C1QC [41]. Worthy of note is the enhanced adsorption of VTNC (1.60-
fold increase) on the 35M35G30T-GEL. This protein induces the osteogenesis by promoting the 
osteoblast differentiation, in the same way as collagen I [42]. This different protein adsorption 
could be related to both the differences in base material characteristics and the distinct gelatin 
linking strategies, which could condition the gelatin conformational organization in the network 
and then the exposure of its functional groups to the serum proteins.   
In the in vivo experiments connective tissue developed and remained around regions of the 
implant surfaces not situated in the proximity of bone tissue. Thus, around the medullary cavity 
portion of 70M30T-coated implants a more fibrous layer was observed. All materials with 
differentially adsorbed proteins related to the complement system or with complement system 
activator proteins (35M35G30T and gelatin formulations) developed a looser connective tissue 
around the implant. Despite of the connective tissue formation, the histology of these materials 
showed proper bone tissue developing and direct bone-implant contact in some areas. The 
incorporation of gelatin indeed had some effect on the induction of a better implant integration, 
as new bone tissue was observed filling the screw grooves on the cortical zone, which is concordant 
with the hypothesis established above, as far as it enhances the osteoblast proliferation and 
differentiation. The increased abundance of complement proteins on some of the materials might 
be sufficiently high to promote the formation of a loose connective tissue layer (e.g. in comparison 
with more fibrous capsules) but not too high to prevent partially good osseointegration. A non- 
chronic immune response is not always undesirable as it favours the tissue growth and 
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regeneration around the implant [3]. In fact, the role of cytokines is not uniquely limited to the 
inflammatory response, as they are described to play a role on osteoblastic activation and/or on 
osteoclast inhibition, thus enhancing bone formation processes [43]. 
One way of measuring the grade of the immune reaction to these materials, might be the 
establishment of an inhibitory/activator ratio of the identified anti-inflammatory proteins, as 
VTNC, in comparison with the pro-inflammatory protein CRP. Applying these criteria, the data 
obtained from the proteomic analysis shows a decrease on these ratios, in particular on the 
materials incorporating gelatin. For example, the ratio VTNC/CRP on the 70M30T material reaches 
a value of 76.05, whilst the same material supplemented with gelatin as a value of 56.71. The same 
finding is observed with the 35M35G30T material, although not having such high values.  
This might be related with the differences between the base materials. Having into account these 
ratios, an appropriate equilibrium between anti- and pro-inflammatory proteins can be desirable 
to avoid a chronic inflammatory response and fibrotic tissue formation. The results obtained from 
the analysis of this ratio are consistent with the in vivo results, in the sense that is visible an increase 
on the inflammatory reaction with a greater presence of multinucleated giant cells around the 
gelatin-supplemented coating on both base materials. This might be explained due to the smaller 
ratio due to the greater adsorption of CRP on them. This fact comes to reinforce the potential of 
proteomic analysis when addressing material biocompatibility, as documented in a previous study 
[44]. 
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e. CONCLUSIONS 
In summary, it has been shown that the base material 35M35G30T may induce overall a higher 
immune response than the other base material 70M30T in vivo. Although in vitro results are not 
concordant with this behaviour, proteomic analysis show effectively more adsorption of proteins 
related to the immune/inflammatory response on the base material 35M35G30T. The in vivo 
behaviour displays that 70M30T base material produces a lower immune response at the period 
tested that increases when adding gelatine while the 35M35G30T formulation induces a higher 
response that also increases when gelatin is added. Overall, the addition of gelatin on each 
material’s matrix, provide an even greater immune response, supported by the fact of the 
adsorption of having more pro-inflammatory proteins adsorbed on the gelatin-silica hybrid sol-gel 
formulations, in particular the CRP, a great activator of the complement cascade. On the 
equilibrium between pro and anti-inflammatory adsorbed proteins may reside the key for a 
prediction of in vivo outcome.  
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8. GENERAL DISCUSSION 
This doctoral thesis has been focused on the possible development and assessment of new 
methodologies in vitro to be applied to biomaterials development, specifically in the dental 
implantology field. These methodologies can represent a significant breakthrough at the moment 
of testing a determined biomaterial for dental application, as they can be potential tools to shirk 
considerable economical and ethical costs related to experimentation.  
Pointedly, the need for an improvement on the standard in vitro experimentation has come due 
to the lack of a well-documented in vitro-in vivo correlation. The in vitro experimentation is critical 
to enable the selection of the materials to be tested in vivo. Moreover, it is a required step to 
reduce the animal experimentation burden. 
The standard in vitro assays to test a new biomaterial for dental application do not ponder the 
whole biological complex processes involved on bone healing post-implantation, as generally only 
osteoblastic cell lines are used, thus focusing more on the osteogenic potential of the material.  
The immune response to a material can be even more defining of implant successfulness on the 
biological context.  
This outcome might be dependent of the type, amount and conformation of the proteins attached 
to the implant on the following moments (days, weeks, months…) after the surgery. Moreover, 
these proteins might condition the osteogenic cellular response to the implant through intricate 
pathways and interplay amongst the proteomic content of the organism adsorbed onto the surface 
of the device. This proteomic content and attachment can condition the immune cell behaviour, 
impairing the healing of the implanted tissue.  
Hence, this thesis was focused on the study of the proteins absorbed in the biomaterials surface 
during first moments post-implantation and its correlation with in vitro and in vivo experimentation. 
To this effect, the three first chapters of this thesis have the focal point on finding some patterns 
regarding finding protein correlations with the in vivo response between materials with a known 
outcome, while the fourth and last chapter was dedicated to the assessment of macrophage 
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phenotypic changes and how to combine this information with proteomic analysis to a better in 
vivo behaviour prediction. 
a) Proteomic analysis as a biocompatibility methodology 
Chapter 1 was focused on characterisation of proteins adhered to two biomaterials with distinct 
outcome: one boosting good biocompatibility and the other with a bad in vivo outcome. At first 
glance, both materials displayed to be non-cytotoxic and presenting good osteoblastic properties, 
making them good candidates to be tested on a living organism. However, the result of assaying 
those materials in vivo did not correlate with the in vitro data. The proteomic assays using blood 
serum deposition onto both materials and consequent LC-MS/MS analysis had sufficient sensitivity 
to show a significant number of proteins more attached to the bad biocompatibility surface, most 
of those directly related to the immune response processes. It was observed a predominance of 
complement-related proteins, namely the increased abundance of CRP (7-fold), a pentraxin 
described to be one of the major activators of the complement system by its binding to C1q. 
This chapter was the first step to validate the possibility of adopting this method as a 
biocompatibility prediction method, as the results were satisfactory.  
b) Validation of the methodology 
Hence, the second study, Chapter 2, was done with the intent of checking if there were any 
differences in regard to the layer of proteins formed onto the surface when comparing two 
biocompatible materials, non-coated bioinert Titanium (SAE-Ti), and a sol-gel hybrid biocompatible 
material 70M30T, the same as used on the first chapter, having in account the immune response 
proteins. However, as expected, considering the outcome on the biological organism context, in 
regard to the cluster of immune response proteins described on the point a), no differences were 
found and osseointegration was achieved on both, which validates the results from the first study. 
Moreover, interestingly, the sol-gel hybrid coating employed showed that the bone healing process 
had some osteoinductive properties, which was corroborated by the gene expression analysis. This 
fact was explainable by the intrinsic Si (OH)4 ion release onto the implant surroundings, enhancing 
the osteoblastic activity, at the same time it explains the lack of differential proteins adsorbed onto 
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the coating. On the other hand, the proteomic analysis showed the greater attachment of proteins 
related to the coagulation and fibrinolysis system on the SAE-Ti, namely PMLN and VTNC, that 
might validate once more the well-documented osteoconductive properties of the material. This 
study not only gave validity to the methodology in the biocompatibility sense, but also made clear 
that this method is sensible enough to make some broad correlations with bone healing processes 
like coagulation and fibrinolysis. 
c) Equilibrium immune response/osteogenesis 
On Chapter 3 our group tested and compared through proteomic characterisation the 
biocompatible material used on the previous chapters (70M30T), against another base material 
developed by our group (35M35G30T), distinguishable by having a GPTMS percentage 
incorporated onto its network. GPTMS has the characteristic of having an epoxy ring on its 
composition, enabling the coating to have bioactive compounds incorporated on its composition. 
Moreover, the main goal of this chapter was to check whether if the incorporation of a molecule 
like gelatin, capable of mimicking collagen I properties, had some effect on protein adsorption, in 
vitro and in vivo experimentation outcome, following the same protocol established for the first 
two chapters. The results displayed an improvement on in vitro osteoblastic cell behaviour 
(enhanced proliferation and mineralization) when gelatin was incorporated. The proteomic 
analysis displayed a greater attachment of proteins related to mineralization on those materials, 
namely Vitronectin (VTNC) and Alpha-2-HS-glycoprotein (FETUA), supporting the osteoblastic 
assays. At the same time, there was increased adsorption of complement-related proteins, among 
those the CRP, which underlies too that gelatin provokes an increased immune response. All of 
these results were validated through the in vivo experimentation, in which is observable a greater 
presence of multinucleated giant cells all around the materials with gelatin, in particular when 
incorporated on the 35M35G30T matrix. However, and although the existence of an increased 
immune reaction, all of the materials reached osseointegration, which could underlie a potential 
equilibrium on the adsorption between anti- and pro-inflammatory to occur the rejection of a 
biomaterial on a biological context. That hypothesis was formulated on this study by establishing 
the ratio between VTNC and CRP. 
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Altogether, the results of this chapter show that the implant outcome could be dependent on an 
established balance between anti- and pro- inflammatory proteins. Moreover, that an increased 
inflammatory response could be favourable to the bone formation processes. 
 
d) Binomial protein adsorption-macrophage polarization 
Finally, the study of Chapter 4 was made with the intent to:  I) prove that the epoxy ring belonging 
to the GPTMS group was the causing agent for the increased inflammation and II) checking if the 
relationship between adsorbed type of inflammation-related proteins and predominance of pro- 
or anti- inflammatory macrophage phenotype. To achieve that, we have tested three materials 
with distinct concentrations of GPTMS, regarding proteomic analysis, in vitro and in vivo behaviour 
concerning inflammatory response, in particular focusing on the macrophage phenotype shift 
when exposed to those materials. Interestingly, our hypothesis was once again validated, showing 
that the materials with GPTMS on its composition have greater affinity, on a dose-dependent 
manner (GPTMS concentration), to immune response proteins. Ficolin-2, CRP, and other 
complement proteins were found significantly more attached on the material with the greatest 
concentration of GPTMS. Moreover, immunocytochemistry and ELISAs assays showed greater 
predominance of M1 macrophages and increased liberation of TNF-α, apart from the slow and 
worst osseointegration around the coating as the amount of GPTMS increases. 
All things considered, once again the proteomic analysis was proven as a potential useful tool to 
predict the inflammatory properties of a determined material. Furthermore, its clear-cut 
correlation with the differentiative and functional macrophage polarization imposes the possibility 
of changes on in vitro testing on a near future. 
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9. Conclusions / Final remarks 
 
From the analysis of the research contained in this doctoral thesis it was possible to partially reply 
to the questions formulated on the objectives: 
 Explicitly, we were able to establish the close relationship between proteins adsorbed 
initially on the biomaterial surface and biological response, not only comprising the 
osteogenesis processes, but also the whole set of processes belonging to bone healing 
post-implantation. 
 
 Inflammation-related proteins, such as CRP and the whole set of complement proteins, 
belonging to the distinct pathways, seem to be intrinsically associated with the 
emergence of biocompatibility problems. 
 
 The macrophage polarization shifts were proven to have some association with the type 
of proteins adsorbed onto a determined biomaterial, with increased inflammatory 
potential onto materials having greater presence of complement proteins on it. 
 
 It might be possible to predict the in vivo outcome of a material regarding inflammatory 
response through assessment of macrophage polarization in vitro. 
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9. Conclusiones  
 
A partir del análisis de la investigación contenida en esta tesis doctoral, se pudo responder 
parcialmente a las preguntas formuladas en el apartado de objetivos: 
• Explícitamente, pudimos establecer la estrecha relación entre las proteínas adsorbidas 
inicialmente en la superficie del biomaterial y la respuesta biológica, que no solo 
comprenden los procesos de osteogénesis, sino también todo el conjunto de procesos 
que pertenecen a la curación ósea después de la implantación.  
 
• Proteínas relacionadas con la inflamación, como la CRP y todo el conjunto de proteínas 
del complemento, pertenecientes a distintas vías, parecen estar intrínsecamente 
asociadas con la aparición de problemas de biocompatibilidad. 
 
• Se demostró que los cambios en la polarización de los macrófagos tienen cierta relación 
con el tipo de proteínas adsorbidas en un determinado biomaterial, con un mayor 
potencial inflamatorio en los materiales que tienen una mayor presencia de proteínas del 
complemento. 
 
• Podría ser posible predecir el resultado in vivo de un material en relación a su respuesta 
inflamatoria a través de la caracterización de la polarización de macrófagos in vitro. 
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9. Conclusions 
A partir de l'anàlisi de la investigació continguda en aquesta tesi doctoral, es va poder respondre 
parcialment a les preguntes formulades en l'apartat d'objectius: 
• Explícitament, vam poder establir l'estreta relació entre les proteïnes adsorbides 
inicialment en la superfície del biomaterial i la resposta biològica, que no només 
comprenen els processos d'osteogènesi, sinó també tot el conjunt de processos que 
pertanyen a la curació òssia després de la implantació. 
 
• Proteïnes relacionades amb la inflamació, com la CRP i tot el conjunt de proteïnes del 
complement, pertanyents a diferents vies, semblen estar intrínsecament associades amb 
l'aparició de problemes de biocompatibilitat. 
 
• Es va demostrar que els canvis en la polarització dels macròfags tenen certa relació amb 
el tipus de proteïnes adsorbides en un determinat biomaterial, amb un major potencial 
inflamatori en els materials que tenen una major presència de proteïnes del complement. 
 
• Podria ser possible predir el resultat in vivo d'un material en relació a la seva resposta 
inflamatòria a través de la caracterització de la polarització de macròfags in vitro. 
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10. Future perspectives 
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10. Future perspectives 
The experimental work developed on this thesis has allowed to remark and underline the 
importance of the type of proteins adhered to a biomaterial surface on post-implantation bone 
tissue healing scenario, especially on the immune response context. The characterisation of the 
proteins adsorbed onto a biomaterial has established a close relationship between them and 
macrophage polarization shift patterns, which are proven to be accountable for an implantation 
successful outcome.  
In that sense, and following the strategy adopted thesis future works to assess macrophage 
polarization onto biomaterials are planned to be carried out, not only focusing on the use of a 
single macrophage behaviour, but also the interaction with, for example, osteoblastic cell lines, on 
a co-culture context. Moreover, our research group has the intention to adopt the use of 3D-
cultures, as they represent a hallmark on this subject, simulating more accurately cell demeanor 
and assess the macrophage plasticity.   Moreover, making use and optimizing distinct techniques 
such as flow cytometry analysis, may serve useful to appraise this phenom, as it identifies precisely 
the macrophage phenotype by the surface markers present on each.  
The use of biocompatible sol-gel materials supplemented with bioactive compounds and 
respective proteomic analysis, which our group has been carried out for the last months, is 
undergoing and will undergo in the near future, aiming to understand the biomaterial-protein-cell-
tissue microenvironment interactions, and how it may affect the bone regenerative processes 
post-implantation. 
On the other hand, studying the layer of proteins adsorbed onto biomaterials regarding other 
processes involved in bone healing, like protein clusters specifically involved on coagulation and 
fibrinolysis may allow us to have a whole perspective to predict whether if a material is more or 
less successful on a biological context. In that sense, right of this moment it is being planned by our 
group an in vivo experimentation to be carried out in osteoporotic models, with the final goal of 
correlating them with proteomic analysis and establishing protein patterns influencing coagulation 
pathways.   
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d. Abbreviation listing 
 ALP  Alkaline Phosphatase 
 ANOVA Analysis of variance 
 BCA Bicinchoninic acid 
 CLR Calcitonin-like receptor 
 COL I Collagen I 
 CR Complement receptors 
 CRP C-reactive protein 
 DAVID Database for Annotation, Visualization and Integrated Discovery´ 
 DMEM Dulbecco’s Modified Eagle’s Medium 
 DTT Dithiothreitol 
 ECM Extracellular Matrix 
 ESI Electrospray ionization 
 FBR Foreign Body Reaction 
 FBS Fetal Bovine Serum 
 FGF Fibroblast Growth Factor 
 GPTMS  3‑glycidoxypropyl-trimethoxysilane 
 HA Hydroxyapatite 
 IGF-1  Insulin growth factor 1 
 Ig Immunoglobulins 
 IL Interleukins 
 LC-MS/MS Liquid Chromatography- Mass Spectromety and tandem mass spectrometry 
 MAC Membrane attack complex 
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 MAPK Mitogen-activated kinase pathway 
 MASP Mannan-binding lectin serine protease 
 MBL Mannan-binding lectin 
 MMP Matrix metalloproteases 
 MSC Mesenquimal stem cells 
 MTMOS Methyltrimethoxysilane 
 OCN Osteocalcin 
 PANTHER Protein ANalysis THrough Evolutionary Relationships 
 PDGF Platelet derived growth factor 
 p-NPP p-nitrophenylphosphate 
 PRR Pattern recognition receptor 
 SAE Sandblasted acid-etched 
 SDS Sodium dodecyl sulfate 
 SEM Scanning electron microscope 
 TEAB Triethylammonium bicarbonate buffer 
 TEOS Tetraethyl-orthosilicate 
 TF Tissue factors 
 TGF-β Transforming growth factor β 
 Th T helper cells 
 Ti Titanium 
 TLR Toll-like receptor 
 TNF-α Tumor necrosis factor alfa 
 tPA Tissue plasminogen activator 
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 uPA Urokinase plasminogen activator 
 VEGF Vascular Endothelial Growth Factor 
 β-TCP β-Tricalcium phosphate 
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e. Figure listing 
Introduction  
Figure 1. The three overlapping phases of bone healing: inflammatory phase, bone formation 
phase and bone remodelling phase. Image collected from [4]. 
Figure 2. Development of the inflammatory processes and cytokine liberation in response to a 
trauma/fracture. 
Figure 3. Development and evolution of the latter phases of bone healing – Bone formation and 
remodelling. 
Figure 4. Processes involved on bone tissue regeneration and interaction between them. 
Figure 5. Pathways of complement activation. Image inspired by [53]. 
Figure 6. Normal macrophage phenotype changes during the formation of new bone. Based on 
[96]. 
Figure 7. Macrophage phenotype change during the formation of fibrous capsule. Based on [96]. 
Figure 8. Evolution of protein deposition and macrophage phenotype modulation onto an implant 
surface. 
Figure 9. The interaction of macrophages with complement. Image based on [108] 
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Chapter 1 
Figure 1. SEM images of sol–gel coated disc surface. 70M30T (a) and 50M50G (b). Calibration bar 
10 mm. 
Figure 2. MC3T3-E1 cell viability and mineralization in vitro. Percentage of cell survival following 
the norm ISO 10993–5 (a). ALP activity (mM PNP/h) normalized to the protein concentration 
(mg/mL) of cells grown without disc (oblicue lines), grown on control Ti discs (horizontal lines), 
70M30G (white column) and 50M50G coated Ti discs (black column). 
Figure 3. In vivo studies. Light microscopy images (EXAKT® cut and Gomori Trichrome stain) from 
in vivo implants 4 and 8 weeks postimplantation of Control-Ti, 70M30T and 50M50G sol–gel coated 
screw; (a) Calibration bar 500 mm; (b) Calibration bar 100 mm. (c) Quantification fibrous of the 
connective tissue area (n=4). Significant values were considered for p<0.05 as analysed by ANOVA 
followed by Newman-Keuls post-test. 
 
Chapter 2 
Figure 1. SEM micrographs of SAE-Ti surfaces and 70M30T sol-gel coating. Calibration bar, 10 µm. 
Figure 2. MC3T3-E1 in vitro assays: A) MC3T3-E1 cell proliferation after 1, 3, 5 and 7 days of 
incubation with SAE-Ti (white bar) and 70M30T (grey bar) materials. B) ALP activity (mM PNP h-1) 
normalised to the amount of total protein (µg µL-1) levels in the MC3T3-E1 cells cultivated on SAE-
Ti (white bar) and 70M30T formulation (grey bar). Cells incubated without discs were used as a 
positive control (black bar). 
Figure 3. Gene expression of osteogenic markers (a) ALP, (b) IL6, (c) COL I and (d) OCN in MC3T3-
E1 osteoblastic cells cultured on SAE-Ti (white bar) and 70M30T (grey bar). The relative mRNA 
expression was determined by RT-PCR after 7 and 14 days of culture. Statistical analysis was 
performed using one-way ANOVA with a Kruskal-Wallis post-test (* p ≤ 0.05). 
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Figure 4. Microphotographs of samples of SAE-Ti and 70M30T implants. The main panels show 4× 
magnification images of regions close to the cortical bone (up) and the bone marrow cavity (down). 
In the inserts (lower-right corners), 10× images of the same regions are shown. 
Figure 5. Bone tissue growth 4 weeks after implantation. Panoramic (left) and detailed (right) 
microphotographs of SAE-Ti and 70M30T implants show the bone tissue generated around the 
implant surface. 
 
Chapter 3 
Figure 1. Scanning electron microscopy images of hybrid sol–gel coatings onto titanium discs: 
70M30T (a), 70M30T‐GEL (b), 35M35G30T (c), and 35M35G30T‐GEL (d). Calibration bar 10 μm. 
Figure 2.  Contact angle measurements of 70M30T, 70M30T‐GEL, 35M35G30T, and 35M35G30T‐
GEL sol–gel coatings. ANOVA (p-value < 0.05). 
Figure 3. MC3T3‐E1 in vitro results. (a) Alkaline phosphatase activity (mM p‐nitrophenol [PNP]/hr) 
normalized to the amount of total protein (μg/μl) levels and (b) proliferation results of the cells 
cultivated on titanium discs treated with 70M30T, 70M30T‐GEL, 35M35G30T, 35M35G30T‐GEL 
formulations. Cells on an empty well without disc were used as a positive control (black column), 
whereas uncoated titanium discs (white column) were used as a negative control ANOVA (p-value 
< 0.05). 
Figure 4. Microphotographs of titanium implants. Panoramic images of (a) 70M30T, (b) 70M30T‐
GEL, (c) 35M35G30T, and (d) 35M35G30TGEL implants. The delineated regions (blue rectangles) in 
the medullary cavity of (a) and (d) images are shown magnified in Figure 5. 
Figure 5. Microscopic detail of areas corresponding to the medullary cavity. Multinucleated cells 
layering the groove surface of (a) 70M30T and (b) 35M35G30T‐GEL implants. The areas shown 
correspond to those delineated in Figure 4. Scale bar, 0.05 mm. 
Figure 6. PANTHER diagram with the biological process of the proteins differentially adhered to 
70M30T‐GEL, respect 70M30T. 
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Figure 7. PANTHER diagram with the biological processes of the proteins differentially adhered to 
35M35G30T (a) and 35M35G30T‐GEL (b). 
 
Chapter 4 
Figure 1. SEM micrographs of 70M30T (a), 35M35G30T (b) and 100G (c) sol-gel coated surfaces. 
Calibration bar 10 µm. (d) Ra values of each formulation (6 measurements). Statistical analysis was 
performed by one-way ANOVA with Newman-Keuls pos-test. *P ≤ 0.05; ** P ≤ 0.01, *** P ≤ 0.001. 
Figure 2. MC3T3-E1 in vitro assays: a) MC3T3-E1 cell survival assay following the norm ISO 10993-
5 standard. Cells in a well without disc were used as a positive control, corresponding to 100% of 
cell viability. b) ALP activity (mM PNP h−1) normalised to the total protein levels (μg μl−1) in the 
MC3T3-E1 cells cultivated on titanium discs with the different formulations tested. There were no 
statistically significant differences between the different formulations. 
Figure 3. Gene expression of osteogenic markers a) IL6, b) TGF-β and c) COL I in MC3T3-E1 
osteoblastic cells cultured onto the different formulations. Relative mRNA expression was 
determined by RT-PCR after 7 and 14 days of culture. Statistical analysis was performed by one-
way ANOVA with Newman-Keuls pos-test. *P ≤ 0.05; ** P ≤ 0.01, *** P ≤ 0.001. 
Figure 4. Cytokine expression of IL1-β (a), TGF-β (b), TNF-α (c) and IL10 (d) by RAW 264.7 
macrophages at 24h and 72h timepoints. Statistical analysis was performed by one-way ANOVA 
with Newman-Keuls pos-test. *P ≤ 0.05; ** P ≤ 0.01, *** P ≤ 0.001. 
Figure 5.  Immunostaining of different types of macrophages cultured onto the 70M30T, 
35M35G30T and 100G sol-gel hybrid formulations after 72h. IL7-R (a’-c’) was used as a pro-
inflammatory M1 marker, while CD206 (a’’-c’’) was used an anti-inflammatory M2 marker.  
Figure 6. Microphotographs of titanium implants. Panoramic images of (a) 70M30T, (b) 
35M35G30T, and (c) 100G implants showing the cortical bone region and the medullary cavity. 
Yellow dashed line in (b) delimits the metal layer of the implant that detached when processing 
the sample. 
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f. Tables listing  
Chapter 1 
Table I. LC-MS/MS Detected Proteins Differentially Predominant in the Film Adsorbed to the 
70M30T Sol–Gel Biomaterial (Progenesis Method). 
Table II. LC-MS/MS detected proteins differentially predominant in the film adsorbed to the 
50M50G sol-gel biomaterial (Progenesis method). The averages are the result of 4 independent 
replicates. Differences were considered significant with an ANOVA p-value < 0.05. DAVID 
classification functions were inflammatory/immune response (1), hydroxylation (2), blood 
coagulation (3), apoptosis regulation (4), metal binding (5), phosphorylation (6), carbohydrate 
binding (7), peptidase activity (8) and cytoskeleton integrity (9).  
 
Chapter 2 
Table I. Proteins differentially attached to 70M30T and Ti (Progenesis analysis). ANOVA (p-value < 
0.05) 
 
Chapter 3 
Table I. The comparison of proteins differentially adhered to 70M30T and 35M35G30T sol-gel 
coatings (Progenesis analysis). ANOVA (p-value < 0.05). 
Table II. The comparison of proteins differentially adhered to 70M30T and 70M30T-GEL hybrid 
coatings (Progenesis analysis). ANOVA (p-value < 0.05). 
Table III. The comparison of proteins adhered to 35M35G30T and 35M35G30T-GEL hybrid coatings 
(Progenesis analysis). ANOVA (p-value < 0.05). 
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Table IV. The comparison of proteins differentially adhered to 35M35G30T-GEL and 70M30T-GEL 
(Progenesis analysis). ANOVA (p-value < 0.05). 
 
 Chapter 4 
Table I. Progenesis analysis of complement-related proteins attached to 70M30T, 35M35G30T and 
100G. Grey background was applied to significant values (ANOVA p<0.05).  
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